Anticoagulants - McMaster Experts

subject area of

"Therapeutic range" for oral anticoagulant therapy. Academic Article
10 Anticoagulant therapy in venous thromboembolism Academic Article
14 Antithrombotic treatment of cerebrovascular disease Academic Article
15 Side-effects of antithrombotic therapy Academic Article
2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Academic Article
2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1 Academic Article
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Academic Article
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants Academic Article
2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis Academic Article
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Academic Article
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer Academic Article
2019 international clinical practice guidelines for the treatment of venous thromboembolism – Authors' reply Academic Article
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants Academic Article
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Academic Article
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 Academic Article
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE Academic Article
6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII Academic Article
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia Academic Article
d-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism Academic Article
d-Dimer Testing to Determine the Duration of Anticoagulation Therapy Academic Article
d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy Academic Article
A 14-year study of heparin-induced thrombocytopenia Academic Article
A 75-Year-Old Man With Congestive Heart Failure Academic Article
A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery Academic Article
A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation Academic Article
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients Academic Article
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis Academic Article
A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism Academic Article
A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism Academic Article
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome Academic Article
A Comparison of the Safety and Efficacy of Oral Antiocoagulation for the Treatment of Venous Thromboembolic Disease in Patients with or without Malignancy Academic Article
A Computer Generated Induction System for Hospitalized Patients Starting on Oral Anticoagulant Therapy Academic Article
A Device on Trial — Intermittent Pneumatic Compression in Critical Care Academic Article
A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures Academic Article
A Historical Perspective on the Reversal of Anticoagulants Academic Article
A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism Academic Article
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction Academic Article
A National Survey of Canadian Practice Patterns of Warfarin After Anterior Wall Myocardial Infarction in the Current Era of Dual Antiplatelet Therapy Academic Article
A New, Simplified Measure of Anticoagulation Control With Warfarin: Potential Role in the Direct Oral Anticoagulant Era Academic Article
A Novel Whole Blood Capillary Technic for Measuring the Prothrombin Time Academic Article
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial Academic Article
A Pilot Study on the Randomization of Inferior Vena Cava Filter Placement for Venous Thromboembolism Prophylaxis in High-Risk Trauma Patients Academic Article
A PoTENtial Antidote Academic Article
A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin Academic Article
A Protease TAMER: a nucleic acid‐based anticoagulant Academic Article
A Randomized Comparison of a Computer-Based Dosing Program with a Manual System to Monitor Oral Anticoagulant Therapy Academic Article
A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses Academic Article
A Replacement for Warfarin Academic Article
A Step Change in Oral Anticoagulation: Lack of Coagulation Monitoring with Ximelagatran Academic Article
A Survey of the Use of Empiric Novel Anticoagulants During Investigation of Stroke Academic Article
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis Academic Article
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement Academic Article
A Systematic Review of Heparin to Treat Burn Injury Academic Article
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score Academic Article
A clinical conundrum: to measure or not measure direct oral anticoagulants before a surgery or procedure? Academic Article
A comparative study of platelet factor 4‐enhanced platelet activation assays for the diagnosis of heparin‐induced thrombocytopenia Academic Article
A comparison of continuous infusion and intermittent flushing methods in peripheral intravenous catheters in neonates. Academic Article
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN) Academic Article
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system Academic Article
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty Academic Article
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation Academic Article
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery Academic Article
A fulminant neurologic presentation of systemic lupus erythematosus Academic Article
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. Academic Article
A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation Academic Article
A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients Academic Article
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program Academic Article
A multicentre randomised clinical endpoint study of parma 5 computer-assisted oral anticoagulant dosage Academic Article
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist. Academic Article
A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury Academic Article
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment Academic Article
A novel antithrombin-heparin covalent complex Academic Article
A novel antithrombotic coronary stent: lysine-poly(HEMA)-modified cobalt–chromium stent with fibrinolytic activity Academic Article
A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation Academic Article
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers Academic Article
A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban Academic Article
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin Academic Article
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study Academic Article
A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery Academic Article
A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin Academic Article
A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design Academic Article
A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions Academic Article
A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin Academic Article
A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I Academic Article
A review of heart failure treatment. Academic Article
A review of the oral direct thrombin inhibitor ximelagatran Academic Article
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction Academic Article
A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation Academic Article
A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal Academic Article
A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism Academic Article
A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies Academic Article
A unified method for regional anticoagulation of blood. Academic Article
AB023, A Novel Antibody That Binds Factor XI and Blocks Its Activation by Factor XIIa Academic Article
ABC of antithrombotic therapy: Valvar heart disease and prosthetic heart valves Academic Article
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies Academic Article
ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery Academic Article
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Academic Article
ASH, ABHH, ACHO, Grupo CAHT, Grupo  CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America Academic Article
Abelacimab for Prevention of Venous Thromboembolism Academic Article
Abelacimab for Prevention of Venous Thromboembolism Academic Article
Accumulating data on rivaroxaban for venous thromboembolism in clinical practice Academic Article
Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy Academic Article
Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals Academic Article
Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Academic Article
Activated protein C in sepsis and beyond: Update 2006 Academic Article
Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia Academic Article
Acute coronary syndromes: a focus on thrombin. Academic Article
Acute intraoperative HIT during heart surgery: Why so rare? Academic Article
Acute management of bleeding in patients on novel oral anticoagulants Academic Article
Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants Academic Article
Acute reversal of anticoagulant-induced bleeding complications. Academic Article
Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria Academic Article
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012 Academic Article
Addressing the burden of hospital‐related venous thromboembolism: the role of extended anticoagulant prophylaxis Academic Article
Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study Academic Article
Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis Academic Article
Adjunctive therapy for myocardial infarction. Academic Article
Advances and contemporary issues in prophylaxis for deep vein thrombosis. Academic Article
Advances in Thrombosis and Hemostasis Academic Article
Advances in anticoagulation: patients with bioprosthetic heart valves Academic Article
Advances in the Management of Acute Venous Thromboembolism and New Therapeutic Agents Academic Article
Advances in the management of venous thromboembolism. Academic Article
Advances in treatment and management Academic Article
Advantages and limitations of the new anticoagulants Academic Article
Adverse Prognostic Significance of Thrombocytopenia in Acute Coronary Syndrome Academic Article
Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study Academic Article
Adverse outcomes associated with managing suspected heparin induced thrombocytopenia in the critically ill Academic Article
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding Academic Article
Agents for the Treatment of Heparin-Induced Thrombocytopenia Academic Article
Airways Disease Presenting as Restrictive Impairment: Response Academic Article
Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation Academic Article
Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation Academic Article
All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis Academic Article
Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study Academic Article
American Association of Orthopedic Surgeons and American College of Chest Physicians Guidelines for Venous Thromboembolism Prevention in Hip and Knee Arthroplasty Differ Academic Article
American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period Academic Article
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy Academic Article
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400. Academic Article
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer Academic Article
American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism Academic Article
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia Academic Article
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy Academic Article
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients Academic Article
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy Academic Article
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer Academic Article
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 Academic Article
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients Academic Article
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients Academic Article
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis Academic Article
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients Academic Article
An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients Academic Article
An Instrument-based Immunoassay with an Appropriate Normal Range: Minimizing HIT Overdiagnosis Academic Article
An International Survey on the Use of Thromboprophylaxis in Urological Surgery Academic Article
An Overview of the Heparin-Induced Thrombocytopenia Syndrome Academic Article
An Update on New Anticoagulants Academic Article
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. Academic Article
An international external quality assessment for laboratory diagnosis of heparin‐induced thrombocytopenia Academic Article
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage Academic Article
An opinion on the benefits of concomitant oral contraceptive therapy in premenopausal women treated with oral anticoagulants Academic Article
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation Academic Article
Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients Academic Article
Analysis of a nonsusceptible fraction with current status data Academic Article
Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study Academic Article
Ancrod (Arvin®) as an Alternative to Heparin Anticoagulation for Cardiopulmonary Bypass Academic Article
Andexanet alfa for the treatment of hemorrhage Academic Article
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis Academic Article
Animal Models of Thrombosis From Zebrafish to Nonhuman Primates Academic Article
Another Dimension of Safety in the Prescription of Anticoagulants for Nonvalvular Atrial Fibrillation Academic Article
Another oral thrombin inhibitor for stroke prevention in atrial fibrillation? Academic Article
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial Academic Article
Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients Academic Article
Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Academic Article
Anticoagulant Actions of Tissue Factor Pathway Inhibitor on Tissue-Factor-Dependent Plasma Coagulation Academic Article
Anticoagulant Treatment of COVID-19 as Early as Possible—Sulodexide and Perspectives Academic Article
Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls Academic Article
Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography Academic Article
Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency Academic Article
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis Academic Article
Anticoagulant response after dalteparin overdose Academic Article
Anticoagulant therapy following acute myocardial infarction. Part I. Incidence of and factors predisposing to thromboembolism associated with acute myocardial infarction. Academic Article
Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions? Academic Article
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis Academic Article
Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome Conference Paper
Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents Academic Article
Anticoagulant-Related Bleeding and Mortality ∗ Academic Article
Anticoagulant-Related Nephropathy Academic Article
Anticoagulants and Gastrointestinal Bleeding Academic Article
Anticoagulants and Their Reversal Academic Article
Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease Academic Article
Anticoagulants in Venous Thromboembolism Academic Article
Anticoagulants in acute coronary syndromes Academic Article
Anticoagulants in atrial fibrillation patients with chronic kidney disease Academic Article
Anticoagulants in cancer Academic Article
Anticoagulants in heart disease: current status and perspectives Academic Article
Anticoagulants in pediatric cerebral sinovenous thrombosis: A safety and outcome study Academic Article
Anticoagulants in pregnancy: A review of indications and complications Academic Article
Anticoagulation Control with Daily Low-Dose Vitamin K to Reduce Clinically Adverse Outcomes and International Normalized Ratio Variability: A Systematic Review and Meta-Analysis Academic Article
Anticoagulation Therapy Academic Article
Anticoagulation Therapy in Children Academic Article
Anticoagulation Therapy in Children Academic Article
Anticoagulation Therapy in Pediatric Patients With Sinovenous Thrombosis Academic Article
Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group Academic Article
Anticoagulation and in vitro fertilization and ovarian stimulation Academic Article
Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target Academic Article
Anticoagulation for Mechanical Heart Valves Academic Article
Anticoagulation for ST-Segment Elevation Myocardial Infarction Academic Article
Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and End-Stage Renal Disease—First, Do No Harm Academic Article
Anticoagulation for cardiopulmonary bypass: Is a replacement for heparin on the horizon? Academic Article
Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding Academic Article
Anticoagulation for patients with atrial fibrillation and risk factors for stroke Academic Article
Anticoagulation for patients with cancer and central venous catheters Academic Article
Anticoagulation for people with cancer and central venous catheters Academic Article
Anticoagulation for people with cancer and central venous catheters Academic Article
Anticoagulation for people with cancer and central venous catheters Academic Article
Anticoagulation for perioperative thromboprophylaxis in people with cancer Academic Article
Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis Academic Article
Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for the prevention of central venous catheter associated-thrombosis: an evidence based commentary Academic Article
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters Academic Article
Anticoagulation for venous thromboembolism Academic Article
Anticoagulation in patients with cancer: an overview of reviews Academic Article
Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target Academic Article
Anticoagulation in venous Thrombosis Academic Article
Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion Academic Article
Anticoagulation of Pregnant Women With Mechanical Heart Valves Academic Article
Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada Academic Article
Anticoagulation therapy for patients with atrial fibrillation. Academic Article
Anticoagulation therapy in 2015: where we are and where we are going Academic Article
Anticoagulation therapy in neonates, children and adolescents Academic Article
Anticoagulation therapy in patients with prosthetic heart valves. Academic Article
Anticoagulation therapy in the antiphospholipid syndrome: recent advances Academic Article
Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients Academic Article
Anticoagulation/platelet inhibition for atrial fibrillation Academic Article
Antidotes for Novel Oral Anticoagulants Academic Article
Antiphospholipid Syndrome During Septic Shock: Hyper- or Hypocoagulability?: A Case Report Academic Article
Antiphospholipid antibiodies: a critical review of the literature Academic Article
Antiphospholipid antibodies and venous thromboembolism Academic Article
Antiphospholipid antibody syndrome: further evidence to guide clinical practice? Academic Article
Antiphospholipid antibody syndrome: recent findings on managing this challenging condition. Academic Article
Antiphospholipid syndrome Academic Article
Antiplatelet Therapy versus Anticoagulation after Surgical Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis Academic Article
Antiplatelet drugs in thromboembolism Academic Article
Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials Academic Article
Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair Academic Article
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations Academic Article
Antithrombin-Heparin Covalent Complex Academic Article
Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin Academic Article
Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model Academic Article
Antithrombotic Activity of the Novel Oral Anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in Animal Models Academic Article
Antithrombotic Agents Academic Article
Antithrombotic Agents in Coronary Artery Disease Academic Article
Antithrombotic Agents in Coronary Artery Disease Academic Article
Antithrombotic Agents in Coronary Artery Disease Academic Article
Antithrombotic Drugs Academic Article
Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation Academic Article
Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
Antithrombotic Therapy for Atrial Fibrillation Academic Article
Antithrombotic Therapy in Coronary Ischaemia: The Expanding Role of Low-Molecular-Weight Heparin Academic Article
Antithrombotic Therapy in Neonates and Children Academic Article
Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty Academic Article
Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention Academic Article
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention Academic Article
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention Academic Article
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Academic Article
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves Academic Article
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves Academic Article
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves Academic Article
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves Academic Article
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts Following Percutaneous Transluminal Coronary Angioplasty Academic Article
Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses Academic Article
Antithrombotic drugs for thromboembolic disorders: A lesson in evidence-based medicine Academic Article
Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding Academic Article
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Academic Article
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents Academic Article
Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves Academic Article
Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation Academic Article
Antithrombotic therapy in aortic diseases: A narrative review Academic Article
Antithrombotic therapy in atrial fibrillation. Academic Article
Antithrombotic therapy in children with venous thromboembolism Academic Article
Antithrombotic therapy: the expanding role of low molecular weight heparin. Academic Article
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme Academic Article
Antithrombotic treatment for peripheral arterial disease Academic Article
Antithrombotics and Anticoagulants in Coronary Syndromes and Stroke Academic Article
Antithrombotics in stable peripheral artery disease Academic Article
Anti‐PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis Academic Article
Anti‐PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non‐drug risk factors and evidence for a stoichiometry‐based model of immunization Academic Article
Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin Academic Article
Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned Academic Article
Apixaban in Acute Coronary Syndromes Academic Article
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement Academic Article
Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients Academic Article
Apixaban versus Enoxaparin in Medically Ill Patients Academic Article
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial Academic Article
Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease Academic Article
Approach to the new oral anticoagulants in family practice: part 1: comparing the options. Academic Article
Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions. Academic Article
Approaches to Diagnosing and Managing Anticoagulant-Related Bleeding Academic Article
Appropriate Apixaban Dosing Academic Article
Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation Academic Article
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery Academic Article
Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials Academic Article
Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials Academic Article
Are NSAIDs Double Trouble? Academic Article
Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin? Academic Article
Are Ticks the Answer to Medical Device-Associated Clotting? Academic Article
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians. Academic Article
Are heparins anti-neoplastic agents? Academic Article
Are older patients with mechanical heart valves at increased risk? Academic Article
Are placebo‐controlled trials ethical in areas where current guidelines recommend therapy? No Academic Article
Are the correct outcomes being measured in studies of oral anticoagulants? A systematic survey Academic Article
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia Academic Article
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Academic Article
Argatroban as a Heparin Substitute in Cases of Heparin-Induced Thrombocytopenia Academic Article
Arteriovenous-Shunt Thrombosis Academic Article
Article Commentary: Heparin and the Peritoneal Membrane Academic Article
Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty Academic Article
Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects. Academic Article
Aspirin for the Prevention of Recurrent Venous Thromboembolism Academic Article
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial Academic Article
Assays for Measuring Rivaroxaban: Their Suitability and Limitations Academic Article
Assessing renal function in patients receiving DOACs: Cockcroft-Gault versus estimated glomerular filtration rate Academic Article
Assessing the impact of dabigatran and warfarin on health-related quality of life: Results from an RE-LY sub-study Academic Article
Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants Academic Article
Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin Academic Article
Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta‐analysis of randomized controlled trials Academic Article
Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH Academic Article
Assessment of the optimal anticoagulant solution for storage of whole blood samples prior to measurement of platelet-associated IgG Academic Article
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients Academic Article
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients Academic Article
Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation Academic Article
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery Academic Article
Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery Academic Article
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials Academic Article
Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure Academic Article
Association of atrial fibrillation with mortality and disability after ischemic stroke Academic Article
Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis Academic Article
Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study Academic Article
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation Academic Article
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism Academic Article
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism Academic Article
At What Age Does Stroke Risk Increase in Patients With Atrial Fibrillation? Does It Depend on Where You Live? Academic Article
Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis Academic Article
Atrial Fibrillation and Cancer—Validation in the Real World—Reply Academic Article
Atrial Fibrillation and PCI — Do We Still Need Aspirin? Academic Article
Atrial Fibrillation in Patients with Cryptogenic Stroke Academic Article
Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke? Academic Article
Atrial fibrillation and stroke: who is low risk and what are we going to do about it? Academic Article
Atrial fibrillation for internists: current practice Academic Article
Atrial fibrillation in a primary care practice: prevalence and management Academic Article
Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation Academic Article
Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope Academic Article
Autoimmune heparin‐induced thrombocytopenia Academic Article
Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review Academic Article
BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study Academic Article
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach Academic Article
Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation Academic Article
Balancing the Risks and Benefits of Oral Anticoagulant Use in Patients With Postoperative Atrial Fibrillation Academic Article
Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers Academic Article
Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey Academic Article
Barriers and facilitators to adopting high value practices and de-adopting low value practices in Canadian intensive care units: a multimethod study Academic Article
Barriers and facilitators to optimal oral anticoagulant management: a scoping review Academic Article
Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: A survey of healthcare professionals Academic Article
Baseline Risks of Venous Thromboembolism and Major Bleeding are Crucial in Decision-making on Thromboprophylaxis Academic Article
Basic and Translational Research in Intracerebral Hemorrhage Academic Article
Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial Academic Article
Benefit of Heparin in Central Venous and Pulmonary Artery Catheters Academic Article
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range Academic Article
Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials Academic Article
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty Academic Article
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease Academic Article
Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials Academic Article
Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness Academic Article
Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) Academic Article
Beyond Unfractionated Heparin and Warfarin Academic Article
Beyond heparin and warfarin: the new generation of anticoagulants Academic Article
Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review Academic Article
Biodistribution of covalent antithrombin-heparin complexes Academic Article
Biologic rationale for the therapeutic role of specific antithrombins Academic Article
Bivalirudin Academic Article
Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. Academic Article
Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Initially Treated with Fondaparinux: Results from an International, Multicenter, Randomized Pilot Study ( Academic Article
Bivalirudin: a review Academic Article
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation Academic Article
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin Academic Article
Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis Academic Article
Bleeding and antidotes in new oral anticoagulants Academic Article
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Academic Article
Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing Academic Article
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry Academic Article
Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk. Academic Article
Bleeding events with dabigatran or warfarin in patients with venous thromboembolism Academic Article
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology Academic Article
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study Academic Article
Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation Academic Article
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents Academic Article
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis Academic Article
Bleeding risks associated with vitamin K antagonists Academic Article
Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience Academic Article
Bleeding with direct oral anticoagulants vs warfarin: clinical experience Academic Article
Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures Academic Article
Bone marrow aspirate collection and preparation – A comparison of three methods Academic Article
Bone marrow biopsy in thrombocytopenic or anticoagulated patients Academic Article
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation Academic Article
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study Academic Article
Brand Name versus Generic Warfarin: A Systematic Review of the Literature Academic Article
Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design Academic Article
Bridging Anticoagulation Academic Article
Bridging Anticoagulation in Patients with Atrial Fibrillation Academic Article
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation Academic Article
Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery Academic Article
Bridging therapy in patients on long‐term oral anticoagulants who require surgery: the Prospective Peri‐operative Enoxaparin Cohort Trial (PROSPECT) Academic Article
Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin Academic Article
Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment Academic Article
Burden of Illness in venous ThromboEmbolism in Critical care: a multicenter observational study Academic Article
CHANGES IN PLATELET BEHAVIOUR DURING ARVIN THERAPY Academic Article
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up Academic Article
Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case Academic Article
Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery? Academic Article
Can we differentiate the low-molecular-weight heparins? Academic Article
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department Academic Article
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention and Treatment of Atrial Fibrillation Following Cardiac Surgery Academic Article
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter Academic Article
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Surgical Therapy Academic Article
Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020 Academic Article
Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy Academic Article
Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study Academic Article
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE Academic Article
Capillary Whole Blood Monitoring of Oral Anticoagulants in Children in Outpatient Clinics and the Home Setting Academic Article
Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation Academic Article
Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial Academic Article
Cardiac Tamponade During Uninterrupted Oral Anticoagulant Therapy for Catheter Ablation for Atrial Fibrillation Academic Article
Cardiac involvement in hypereosinophilic syndrome Academic Article
Cardioembolic Stroke Academic Article
Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients Academic Article
Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants Academic Article
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial) Academic Article
Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial Academic Article
Care of Patients Receiving Long-Term Anticoagulant Therapy Academic Article
Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention Academic Article
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF Academic Article
Causes of Death and Influencing Factors in Patients With Atrial Fibrillation Academic Article
Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia Academic Article
Central venous catheters are an important factor in paediatric thrombosis Academic Article
Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach Academic Article
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial Academic Article
Certainty ranges facilitated explicit and transparent judgments regarding evidence credibility Academic Article
Cervical artery dissection: Pathology, epidemiology and management Academic Article
Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity Academic Article
Challenging anticoagulation cases: A case of acute pulmonary embolism in a patient with chronic thrombocytopenia Academic Article
Change in Thrombus Length on Venous Ultrasound and Recurrent Deep Vein Thrombosis Academic Article
Changes in Renal Function in Patients With Atrial Fibrillation Academic Article
Changes in renal cortical and medullary perfusion in a patient with renal vein thrombosis. Academic Article
Changing Paradigms in the Management of Venous Thromboembolism Academic Article
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry Academic Article
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial Academic Article
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry Academic Article
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study) Academic Article
Characterization of Heparin Aerosols Generated in Jet and Ultrasonic Nebulizers Academic Article
Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin‐induced thrombocytopenia Academic Article
Chemical–Physical Characterization of Polyurethane Catheters Modified with a Novel Antithrombin-Heparin Covalent Complex Academic Article
Choice of Platelet Anticoagulants Academic Article
Cholesterol microembolization syndrome Academic Article
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1 Academic Article
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2 Academic Article
Ciraparantag as a potential universal anticoagulant reversal agent Academic Article
Ciraparantag: the next anticoagulant airbag? Academic Article
Circulating heparin‐like anticoagulants: Case report and review of literature Academic Article
Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism Academic Article
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study Academic Article
Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism Academic Article
Clinical Outcomes in Atrial Fibrillation Research Academic Article
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy Academic Article
Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective Academic Article
Clinical Validity of a Normal Perfusion Lung Scan in Patients with Suspected Pulmonary Embolism Academic Article
Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin‐induced thrombocytopenia Academic Article
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials Academic Article
Clinical factors influencing the sensitivity to warfarin when restarted after surgery Academic Article
Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis Academic Article
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry Academic Article
Clinical implications of incidental venous thromboembolism in cancer patients Academic Article
Clinical implications of reversal agents for direct oral anticoagulants Academic Article
Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry Academic Article
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia Academic Article
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin Academic Article
Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications Academic Article
Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin‐induced thrombocytopenia (HIT) Academic Article
Clinical significance and management of subsegmental pulmonary embolism Academic Article
Clinical trials of deep vein thrombosis prophylaxis in medical patients Academic Article
Clinical trials of new anticoagulants. Academic Article
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study Academic Article
Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Academic Article
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Academic Article
Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices Academic Article
Coagulation Assays Academic Article
Coagulation Factor IXa as a Target for Treatment and Prophylaxis of Venous Thromboembolism Academic Article
Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass Academic Article
Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure Academic Article
Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation Academic Article
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease Academic Article
Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study Academic Article
Combination of two complementary automated rapid assays for diagnosis of heparin‐induced thrombocytopenia (HIT) Academic Article
Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why? Academic Article
Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease Academic Article
Combined antiplatelet and anticoagulant therapy: clinical benefits and risks Conference Paper
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist Academic Article
Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it? Academic Article
Comment on model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients Academic Article
Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel” Academic Article
Comment: Treatment of Heparin-Induced Thrombocytopenia Academic Article
Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole Academic Article
Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis: A Survey on Anticoagulation for Mechanical Heart Valves in Pregnancy Academic Article
Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis Academic Article
Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study Academic Article
Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol Academic Article
Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study Academic Article
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? Academic Article
Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE Academic Article
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes Academic Article
Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study Academic Article
Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials Academic Article
Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades Academic Article
Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis Conference Paper
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor Academic Article
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy Academic Article
Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin Academic Article
Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Academic Article
Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome Academic Article
Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy Academic Article
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism Academic Article
Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes Academic Article
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism Academic Article
Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease Academic Article
Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement Academic Article
Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial Academic Article
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) Academic Article
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial Academic Article
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial Academic Article
Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial Academic Article
Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model Academic Article
Comparison of the Villalta post‐thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis Academic Article
Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial Academic Article
Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations Academic Article
Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models Academic Article
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism Academic Article
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Academic Article
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis. Academic Article
Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers Academic Article
Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials Academic Article
Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients Academic Article
Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism Academic Article
Complement and the antiphospholipid syndrome Academic Article
Comprehensive upstream treatment for atrial fibrillation, when and how? Academic Article
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial Academic Article
Concentration of meropenem in patients with sepsis and acute kidney injury before and after initiation of continuous renal replacement therapy: a prospective observational trial Academic Article
Concomitant Surgical Left Atrial Appendage Occlusion: a Review Academic Article
Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial Academic Article
Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies – distinguishing "signal" from "noise" Academic Article
Confusion Over the Therapeutic Range for Monitoring Oral Anticoagulant Therapy in North America Academic Article
Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology Academic Article
Conservative management of neonatal cerebral sinovenous thrombosis with coexisting thrombophilia Academic Article
Considerations when prescribing trimethoprim-sulfamethoxazole Academic Article
Continued versus interrupted direct oral anticoagulation for cardiac electronic device implantation: A systematic review Academic Article
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2) Academic Article
Continuing Challenges of Sepsis Research Academic Article
Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery” Academic Article
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Academic Article
Conversion of thrombin into an anticoagulant by protein engineering Academic Article
Cost Effectiveness of Continued-Warfarin Versus Heparin-Bridging Therapy During Pacemaker and Defibrillator Surgery Academic Article
Cost effectiveness of LAA closure in patients with AF and contraindications to warfarin: comment Academic Article
Cost prediction models for the comparison of two groups Academic Article
Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis Academic Article
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation Academic Article
Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist Academic Article
Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation Academic Article
Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients Academic Article
Costs of Outpatient Anticoagulant Treatment in Patients with Cerebral and Peripheral Arterial Occlusive Disease Academic Article
Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis Academic Article
Covalent Antithrombin-Heparin Complexes with High Anticoagulant Activity Academic Article
Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate Complexes Academic Article
Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va Academic Article
Covalent antithrombin–heparin complexes Academic Article
Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets Academic Article
Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism. Academic Article
Current agents for the treatment of patients with heparin-induced thrombocytopenia Academic Article
Current anticoagulant therapy—unmet clinical needs Conference Paper
Current strategies in prophylaxis and treatment of venous thromboembolism Academic Article
D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders Academic Article
D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy Academic Article
D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment Academic Article
DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines Academic Article
DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature Academic Article
Dabigatran Etexilate Academic Article
Dabigatran Etexilate: Future Directions in Anticoagulant Treatment Academic Article
Dabigatran Versus Warfarin Academic Article
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation Academic Article
Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation Academic Article
Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management Academic Article
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? Academic Article
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial Academic Article
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE‐LY trial Academic Article
Dabigatran efficacy‐safety assessment for stroke prevention in patients with atrial fibrillation Academic Article
Dabigatran etexilate and reduction in serum apolipoprotein B Academic Article
Dabigatran etexilate for prevention of venous thromboembolism Academic Article
Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial Academic Article
Dabigatran in Patients with Mechanical Heart Valves Academic Article
Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation Academic Article
Dabigatran monitoring made simple? Academic Article
Dabigatran reversal by idarucizumab in the setting of intracranial hemorrhage: A systematic review of the literature Academic Article
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II. Academic Article
Dabigatran versus Warfarin for Venous Thromboembolism Academic Article
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Academic Article
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves Academic Article
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism Academic Article
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada Academic Article
Dabigatran versus warfarin in patients with mechanical heart valves: reply Academic Article
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study Academic Article
Dabigatran: ready for prime time? Academic Article
Dalteparin and Heparin-Induced Thrombocytopenia Academic Article
Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency Academic Article
Dalteparin versus Unfractionated Heparin in Critically Ill Patients Academic Article
Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients Academic Article
Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3) Academic Article
Dealing with Drug-Induced Thrombocytopenia Academic Article
Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol Academic Article
Decision‐analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injury Academic Article
Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009) Academic Article
Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential Academic Article
Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass Academic Article
Decreasing warfarin sensitivity during the first three months after heart valve surgery: Implications for dosing Academic Article
Deep Vein Thrombosis Prophylaxis in Hospitalized Medical Patients: Current Recommendations, General Rates of Implementation, and Initiatives for Improvement Academic Article
Deep Vein Thrombosis and Its Prevention in Critically Ill Adults Academic Article
Deep vein thrombosis Academic Article
Deep vein thrombosis prophylaxis in the outpatient setting: preventing complications following hospital discharge. Academic Article
Deep vein thrombosis: update on diagnosis and management Academic Article
Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors Academic Article
Deep venous thrombosis in the medically ill. Academic Article
Deep-Vein Thrombosis Academic Article
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention Academic Article
Defining the heparin-binding domain of antithrombin Academic Article
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients Academic Article
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients Academic Article
Definition of major bleeding used by US anticoagulation clinics Academic Article
Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department Academic Article
Delayed-Onset Heparin-Induced Thrombocytopenia and Cerebral Thrombosis after a Single Administration of Unfractionated Heparin Academic Article
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis Academic Article
Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis Academic Article
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum Academic Article
Demand on-demand testing for the diagnosis of heparin-induced thrombocytopenia Academic Article
Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. Academic Article
Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home Academic Article
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)–5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non–ST-segment elevation acute coronary syndromes Academic Article
Design of the rivaroxaban for heparin-induced thrombocytopenia study Academic Article
Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis Academic Article
Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial Academic Article
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis Academic Article
Development of the IRIS-AR strategy: an intervention to improve rates of accrual and retention for the VTE-PRO randomized controlled trial Academic Article
Device Surgery without Interruption of Anticoagulation Academic Article
Device surgery without interruption of anticoagulation. Academic Article
Diagnosing central nervous system vasculitis in children Academic Article
Diagnosis and Anticoagulant Treatment Academic Article
Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation Academic Article
Diagnostic Efficacy of Impedance Plethysmography for Clinically Suspected Deep-Vein Thrombosis Academic Article
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice Academic Article
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation Academic Article
Differences in the safety profiles of two low-molecular-weight heparins Academic Article
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis Academic Article
Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation Academic Article
Direct Factor Xa and direct thrombin inhibitors: a clinical trial update. Academic Article
Direct Oral Anticoagulant Dosing in Extremes of Body Weight: Time to Revisit the Guidelines? Academic Article
Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding Academic Article
Direct Oral Anticoagulants Academic Article
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis Academic Article
Direct Oral Anticoagulants and Myocardial Infarction Academic Article
Direct Oral Anticoagulants in the Real World Academic Article
Direct Thrombin Inhibitors in Acute Coronary Syndromes Academic Article
Direct and indirect costs of management of long‐term warfarin therapy in Canada Academic Article
Direct oral anticoagulants Academic Article
Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information Academic Article
Direct oral anticoagulants after bariatric surgery—What is the evidence? Academic Article
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Academic Article
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis Academic Article
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review Academic Article
Direct oral anticoagulants: evidence and unresolved issues Academic Article
Direct thrombin inhibitors Academic Article
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention Academic Article
Direct-Acting Oral Anticoagulants Academic Article
Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia Academic Article
Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry Academic Article
Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis Academic Article
Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial Academic Article
Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? Academic Article
Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? Academic Article
Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism? Academic Article
Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests? Academic Article
Does rhythm or rate control strategy influence anticoagulant treatment in older patients with atrial fibrillation? Data from REPOSI Academic Article
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis Academic Article
Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/ Academic Article
Dose Capping Enoxaparin Is Unjustified and Denies Patients With Acute Coronary Syndromes a Potentially Effective Treatment Academic Article
Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement Academic Article
Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary Syndrome Academic Article
Double Blind Pilot Randomized Trial Comparing Extended Anticoagulation to Placebo Following Major Lung Resection for Cancer Academic Article
Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review Academic Article
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence Academic Article
Dual surface modification with PEG and corn trypsin inhibitor: Effect of PEG:CTI ratio on protein resistance and anticoagulant properties Academic Article
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease Academic Article
Duration of Anticoagulant Therapy for Venous Thrombosis Academic Article
Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH Academic Article
Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia Academic Article
Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism Academic Article
Duration of anticoagulant therapy for venous thromboembolism Academic Article
Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials Academic Article
Duration of anticoagulants in acute or recurrent venous thromboembolism Academic Article
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference Academic Article
ENNOBLE-ATE trial: an open-label, randomised, multi-centre, observational study of edoxaban for children with cardiac diseases at risk of thromboembolism Academic Article
Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial Academic Article
Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positive Academic Article
Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis Academic Article
Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review Academic Article
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]. Academic Article
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial Academic Article
Editorial Commentary: A Patient-Specific Approach to Preventing Venous Thromboembolism After Hip Arthroscopy Is Essential Academic Article
Editorial Commentary: Don't Worry About It—Hip Arthroscopy Is Safe From Venous Thromboembolism…Mostly Yes! Academic Article
Edoxaban and amiodarone: interactions on multiple levels Academic Article
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease Academic Article
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Academic Article
Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer Academic Article
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study Academic Article
Edoxaban for treatment of venous thromboembolism in patients with cancer Academic Article
Edoxaban versus Warfarin in Patients with Atrial Fibrillation Academic Article
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial Academic Article
Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation Academic Article
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism Academic Article
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect Academic Article
Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma Academic Article
Effect of Drugs on Platelets and Complications of Vascular Disease Article
Effect of Heparin Loading During Congenital Heart Operation on Thrombin Generation and Blood Loss Academic Article
Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate Academic Article
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty Academic Article
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature Academic Article
Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin Academic Article
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy Academic Article
Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium Academic Article
Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study Academic Article
Effect of covalent antithrombin-heparin complex on developmental mechanisms in the lung Academic Article
Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis Academic Article
Effect of gaboon viper (Bitis gabonica) venom on blood coagulation, platelets, and the fibrinolytic enzyme system Academic Article
Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA. Academic Article
Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis Academic Article
Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure Academic Article
Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro Academic Article
Effect of sulfonation of segmented polyurethanes on the transient adsorption of fibrinogen from plasma: Possible correlation with anticoagulant behavior Academic Article
Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survival Academic Article
Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography Academic Article
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes Academic Article
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism Academic Article
Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events Academic Article
Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi‐database cohort study with meta‐analysis Academic Article
Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials Academic Article
Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min Academic Article
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state Academic Article
Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism Academic Article
Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism Academic Article
Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1 Academic Article
Effectiveness of Anticoagulants Academic Article
Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials Academic Article
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial Academic Article
Effects of Heat/Citric Acid Reprocessing on High-Flux Polysulfone Dialyzers Academic Article
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation Academic Article
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment Academic Article
Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth Academic Article
Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review Academic Article
Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina Academic Article
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: comment Academic Article
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants Academic Article
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation Academic Article
Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation Academic Article
Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial - Academic Article
Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism Academic Article
Efficacy and Safety of Fixed Low-Dose Dalteparin in Preventing Venous Thromboembolism Among Obese or Elderly Hospitalized Patients Academic Article
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines Academic Article
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Academic Article
Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients Academic Article
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 Academic Article
Efficacy and Safety of Warfarin VS. Antiplatelet Therapy in Patients with Systolic Heart Failure and Sinus Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Academic Article
Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation Academic Article
Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial Academic Article
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Academic Article
Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis Academic Article
Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement Academic Article
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment Academic Article
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial Academic Article
Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial Academic Article
Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves Academic Article
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER^®, RE-COVER™ II, and RE-MEDY™ Academic Article
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation Academic Article
Embolic Stroke of Undetermined Source Academic Article
Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants Academic Article
Emerging Anticoagulant Drugs Academic Article
Emerging anticoagulant strategies Academic Article
Emerging anticoagulants for the treatment of venous thromboembolism Academic Article
Emerging themes in the treatment of venous thromboembolism Academic Article
End of the road for heparin thromboprophylaxis Academic Article
Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis Academic Article
Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles Academic Article
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction Academic Article
Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years Academic Article
Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty Academic Article
Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates Academic Article
Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery Academic Article
Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Academic Article
Epidemiology of Thrombosis in Cancer Academic Article
Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant—Reply Academic Article
Establishing an Optimal Therapeutic Range for Coumarins Academic Article
Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke Academic Article
Ethnoracial variations in venous thrombosis: Implications for management, and a call to action Academic Article
Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants Academic Article
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis Academic Article
Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study Academic Article
Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents Academic Article
Evaluation of a Thromboprophylaxis Quality Improvement Project in a Palliative Care Unit Academic Article
Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy Academic Article
Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting. Academic Article
Evaluation of direct oral anticoagulants in superficial-vein thrombosis – Authors' reply Academic Article
Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation Academic Article
Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials Academic Article
Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant. Academic Article
Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis Academic Article
Evidence and Clinical Judgment: Vena cava filters Academic Article
Evidence based treatment of the antiphospholipid syndromeII. Optimal anticoagulant therapy for thrombosis Academic Article
Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis Academic Article
Evidence-based treatment of the antiphospholipid syndrome Academic Article
Evolving Treatments for Arterial and Venous Thrombosis Academic Article
Evolving use of new oral anticoagulants for treatment of venous thromboembolism Academic Article
Exaggerated initial response to warfarin following heart valve replacement Academic Article
Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial Academic Article
Executive Summary Academic Article
Executive Summary Academic Article
Exercise-Induced Deep Vein Thrombosis of the Upper Extremity Academic Article
Exercise-Induced Deep Vein Thrombosis of the Upper Extremity Academic Article
Exosites 1 and 2 Are Essential for Protection of Fibrin-bound Thrombin from Heparin-catalyzed Inhibition by Antithrombin and Heparin Cofactor II Academic Article
Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolism Academic Article
Extended DOAC therapy in patients with VTE and potential risk of recurrence: A systematic review and meta‐analysis Academic Article
Extended Treatment of Venous Thromboembolism Academic Article
Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study Academic Article
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study Academic Article
Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy? Academic Article
Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review Academic Article
Extended treatment of venous thromboembolism. Academic Article
Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility Academic Article
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials Academic Article
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study Academic Article
Extended‐duration new oral anticoagulants for venous thromboprophylaxis in patients undergoing total hip arthroplasty: a meta‐analysis of the randomized controlled trials Academic Article
Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood Academic Article
Extension of anticoagulation after venous thromboembolism Academic Article
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Academic Article
Factor XI Antisense Oligonucleotide for Venous Thrombosis Academic Article
Factor XI and factor XII as targets for new anticoagulants Academic Article
Factor XI as a Target for New Anticoagulants Academic Article
Factor XI inhibitors: cardiovascular perspectives Academic Article
Factor XI inhibitors: what should clinicians know Academic Article
Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi Academic Article
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial Academic Article
Factor Xa and thrombin as targets for new oral anticoagulants Academic Article
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism Academic Article
Factors affecting stability of plasma brain-derived neurotrophic factor Academic Article
Failure of Anticoagulant Thromboprophylaxis Academic Article
Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records Academic Article
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists Academic Article
FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia Academic Article
Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols Academic Article
Feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates Academic Article
Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study Academic Article
Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT Academic Article
Fifty years of research on antithrombotic therapy: Achievements and disappointments Academic Article
Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty Academic Article
Flexibility in Administration of Fondaparinux for Prevention of Symptomatic Venous Thromboembolism in Orthopaedic Surgery Academic Article
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control Academic Article
Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy Academic Article
Fondaparinux Reduces Long-term Risk of Venous Thromboembolism After Surgery for Hip Fractur Academic Article
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double‐blind comparison Academic Article
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk Academic Article
Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia Academic Article
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs Academic Article
Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study Academic Article
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction Academic Article
Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6 Academic Article
Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke Academic Article
Fondaparinux treatment of acute heparin‐induced thrombocytopenia confirmed by the serotonin‐release assay: a 30‐month, 16‐patient case series Academic Article
Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial Academic Article
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin Academic Article
Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle> Academic Article
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux Academic Article
Fondaparinux – evolution or revolution in anticoagulant care? Academic Article
Fondaparinux: does it cause HIT? can it treat HIT? Academic Article
For How Long Should the Treatment with Vitamin K Antagonists Be Maintained? Conference Paper
Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding Academic Article
Fragmin in Unstable Angina Pectoris or in Non-Q-Wave Acute Myocardial Infarction (the FRIC Study) Academic Article
Frequency of Heparin-Induced Thrombocytopenia in Critical Care Patients Academic Article
Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study Academic Article
From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer Academic Article
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE) Academic Article
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation Academic Article
GASTROINTESTINAL BLEEDING AFTER ACUTE ISCHEMIC STROKE Academic Article
Gastrointestinal Bleeding With Edoxaban Versus Warfarin Academic Article
Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies Academic Article
Gender and left atrial appendage occlusion: Not the exception in cardiovascular procedures Academic Article
General Discussion Academic Article
General mechanisms of coagulation and targets of anticoagulants (Section I) Academic Article
Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding Academic Article
Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy Academic Article
Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation Academic Article
Getting intimate with the venous thrombus Academic Article
Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE) Academic Article
Global access to affordable direct oral anticoagulants Academic Article
Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH Academic Article
Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial Academic Article
Guidance for the treatment of deep vein thrombosis and pulmonary embolism Academic Article
Guide to Anticoagulant Therapy: Heparin Academic Article
Guide to Anticoagulant Therapy: Heparin Academic Article
Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association. Academic Article
Guidelines for anticoagulant use in acute coronary syndromes Academic Article
Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation. Academic Article
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU Academic Article
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU Academic Article
Guidelines for the management of acute coronary syndromes 2006 Academic Article
HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions Academic Article
HERDOO2 identified women at low risk for recurrence after 5 to 12 mo of anticoagulation for a first unprovoked VTE Academic Article
HFSA Guidelines for Management of Patients With Heart Failure Caused by Left Ventricular Systolic Dysfunction—Pharmacological Approaches Academic Article
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches Academic Article
HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT Academic Article
HITlights: A career perspective on heparin-induced thrombocytopenia Academic Article
Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants. Academic Article
Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin Academic Article
Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis Academic Article
Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding Academic Article
Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study Academic Article
Hemorrhagic Complications of Anticoagulant Therapy Academic Article
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment Academic Article
Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated? Academic Article
Hemorrhagic complications of anticoagulant treatment. Academic Article
Hemorrhagic complications of anticoagulant treatment. Academic Article
Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease. Academic Article
Hemorrhagic complications of long-term anticoagulant therapy. Academic Article
Hemorrhagic complications of long-term anticoagulant therapy. Academic Article
Hemostasis and atherosclerosis. Academic Article
Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Academic Article
Heparin Brand Is Associated With Postsurgical Outcomes in Children Undergoing Cardiac Surgery Academic Article
Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate Academic Article
Heparin Improves Gas Exchange during Experimental Acute Lung Injury in Newborn Piglets Academic Article
Heparin Thromboprophylaxis in Medical-Surgical Critically Ill Patients Academic Article
Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss Academic Article
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety Academic Article
Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases Academic Article
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far? Academic Article
Heparin for prolonging peripheral intravenous catheter use in neonates Academic Article
Heparin induced thrombocytopenia Academic Article
Heparin or nonheparin anticoagulants for VITT Academic Article
Heparin resistance in acute coronary syndromes Academic Article
Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns Academic Article
Heparin, Low Molecular Weight Heparin, and Heparin-Induced Thrombocytopenia in the ICU Academic Article
Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome Academic Article
Heparin-Induced Thrombocytopenia Academic Article
Heparin-Induced Thrombocytopenia Academic Article
Heparin-Induced Thrombocytopenia Academic Article
Heparin-Induced Thrombocytopenia Academic Article
Heparin-Induced Thrombocytopenia Academic Article
Heparin-Induced Thrombocytopenia Associated with Fondaparinux Academic Article
Heparin-Induced Thrombocytopenia Presenting as Bilateral Adrenal Hemorrhages Academic Article
Heparin-Induced Thrombocytopenia and Vascular Surgery Academic Article
Heparin-Induced Thrombocytopenia in Critically Ill Patients Academic Article
Heparin-Induced Thrombocytopenia in Critically Ill Patients Academic Article
Heparin-Induced Thrombocytopenia in Medical Surgical Critical Illness Academic Article
Heparin-Induced Thrombocytopenia in Patients with Ventricular Assist Devices: Are New Prevention Strategies Required? Academic Article
Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing Academic Article
Heparin-Induced Thrombocytopenia: A Clinicopathologic Syndrome Academic Article
Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective Academic Article
Heparin-Induced Thrombocytopenia: An Iceberg Rising Academic Article
Heparin-Induced Thrombocytopenia: Real-World Issues Academic Article
Heparin-induced Thrombocytopenia: Towards Consensus Academic Article
Heparin-induced Thrombocytopenia: Yet Another Treatment Paradox? Academic Article
Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes Academic Article
Heparin-induced thrombocytopenia Academic Article
Heparin-induced thrombocytopenia Academic Article
Heparin-induced thrombocytopenia and cardiac surgery Academic Article
Heparin-induced thrombocytopenia and cardiac surgery Academic Article
Heparin-induced thrombocytopenia and its treatment. Conference Paper
Heparin-induced thrombocytopenia and the anesthesiologist. Academic Article
Heparin-induced thrombocytopenia in intensive care patients Academic Article
Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass Academic Article
Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^ Academic Article
Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial Academic Article
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings Academic Article
Heparin-induced thrombocytopenia: What the serologists have taught us Academic Article
Heparin-induced thrombocytopenia: an overview Academic Article
Heparin-induced thrombocytopenia: pathogenesis and management Academic Article
Heparin-induced thrombocytopenia: pathogenesis and management Academic Article
Heparin-induced thrombocytopenia: patient profiles and clinical manifestations. Academic Article
Heparin-induced thrombosis without thrombocytopenia Academic Article
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
Heparins in sepsis-induced disseminated intravascular coagulation: Low weight—high impact?* Academic Article
Heparin‐induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HIT Academic Article
High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis Academic Article
High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT Academic Article
Higher-quality evidence needed before abandoning proven therapies: Comment Academic Article
Higher-risk APS: do we dare to DOAC? Academic Article
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14–16, 2010, São Paulo, Brazil Academic Article
Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20–21, 2011, Salvador, Bahia, Brazil Academic Article
Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil Academic Article
High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome Academic Article
Hirudin and thrombosis prophylaxis Academic Article
Hirudin causes more bleeding than heparin in a rabbit ear bleeding model Academic Article
Home prophylactic warfarin anticoagulation program after hip and knee arthroplasty. Academic Article
Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis Academic Article
Home-monitoring of oral anticoagulation vs. dabigatran Academic Article
Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone Academic Article
How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review Academic Article
How Did We Get Here?: A Historical Review and Critical Analysis of Anticoagulation Therapy Following Mechanical Valve Replacement Academic Article
How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism Academic Article
How I treat anticoagulated patients undergoing an elective procedure or surgery Academic Article
How I treat heavy menstrual bleeding associated with anticoagulants Academic Article
How I treat patients with a history of heparin-induced thrombocytopenia Academic Article
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy Academic Article
How I treat target-specific oral anticoagulant–associated bleeding Academic Article
How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch Academic Article
How can we reverse bleeding in patients on direct oral anticoagulants? Academic Article
How do family medicine residents choose an anticoagulation regimen for patients with nonvalvular atrial fibrillation? Academic Article
How long is long enough for pharmacological thromboprophylaxis in urology? Academic Article
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society Academic Article
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice Academic Article
How to use unfractionated heparin to treat neonatal thrombosis in clinical practice Academic Article
How we diagnose and treat deep vein thrombosis Academic Article
Hypercoagulability and coronavirus disease 2019–associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms Academic Article
Hypercoagulability preceding cancer Academic Article
Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase Academic Article
Hypothenar Hammer Syndrome From Ice Hockey Stick-Handling Academic Article
IMPACT OF MUTATIONS AT THE P4 AND P5 POSITIONS ON THE REACTION OF ANTITHROMBIN WITH THROMBIN AND ELASTASE Academic Article
INR reporting in Canadian medical laboratories. Thrombosis Interest Group of Canada. Academic Article
ISTH DIC subcommittee communication on anticoagulation in COVID‐19 Academic Article
ISTH guidelines for antithrombotic treatment in COVID‐19 Academic Article
Iatrogenic causes of an ICH Academic Article
Idarucizumab for Dabigatran Reversal Academic Article
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis Academic Article
Identifying Patients With Atrial Fibrillation in Administrative Data Academic Article
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy Academic Article
Idrabiotaparinux treatment for venous thromboembolism Academic Article
Imaging for Atrial Fibrillation Academic Article
Immobilization of an antithrombin–heparin complex on gold: Anticoagulant properties and platelet interactions Academic Article
Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin Academic Article
Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies Academic Article
Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting Academic Article
Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial Academic Article
Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy Academic Article
Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients Academic Article
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta‐analysis Academic Article
Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry Academic Article
Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk Academic Article
Impact of the patient population on the risk for heparin-induced thrombocytopenia Academic Article
Impact of thrombophilia screening on venous thromboembolism management practices Academic Article
Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement Academic Article
Improved Bovine ICSI Outcomes by Sperm Selected after Combined Heparin-Glutathione Treatment Academic Article
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation Academic Article
Improving Clinical Interpretation of the Anti-Platelet Factor 4/Heparin Enzyme-Linked Immunosorbent Assay for the Diagnosis of Heparin-Induced Thrombocytopenia Through the Use of Receiver Operating Characteristic Analysis, Stratum-Specific Likelihood Ratios, and Bayes Theorem Academic Article
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Academic Article
Improving the adoption of optimal venous thromboembolism prophylaxis in critically ill patients: A process evaluation of a complex quality improvement initiative Academic Article
In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age Academic Article
In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding Academic Article
In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS₂and CHA₂DS₂-VASc Academic Article
In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days Academic Article
In reply: Low‐molecular‐weight heparins and heparinoids Academic Article
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation Academic Article
In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding Academic Article
In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits Academic Article
In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex Academic Article
In-Vitro Studies with Ancrod (‘Arvin’) Academic Article
Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgery Academic Article
Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy Academic Article
Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study Conference Paper
Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism Academic Article
Incidence of Direct Oral Anticoagulant Prescriptions in Kidney Transplant Recipients in Ontario, Canada Academic Article
Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy Academic Article
Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta-analysis of prospective studies Academic Article
Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer Academic Article
Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study Academic Article
Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study Academic Article
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation Academic Article
Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries Academic Article
Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate Academic Article
Incremental Value of Left Ventricular Systolic and Diastolic Function to Determine Outcome in Patients with Acute ST-Segment Elevation Myocardial Infarction: The Echocardiographic Substudy of the OASIS-6 Trial Academic Article
Indications, Complications, and Management of Inferior Vena Cava Filters Academic Article
Indications, complications and outcomes of inferior vena cava filters: A retrospective study Academic Article
Indirect comparison: relative risk fallacies and odds solution Academic Article
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale Academic Article
Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation Academic Article
Individualized Care in Patients with Chronic Congestive Heart Failure Academic Article
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial Academic Article
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials Academic Article
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial Academic Article
Influenza Vaccination and Vitamin K Antagonist Treatment Academic Article
Influenza vaccination in patients on long-term anticoagulant therapy Academic Article
Inherited thrombophilia and pregnancy associated venous thromboembolism Academic Article
Inhibition of Warfarin Activity by Ribavirin Academic Article
Inhibition of osteolytic bone metastasis by unfractionated heparin Academic Article
Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes. Academic Article
Inhibition of the prothrombinase complex on red blood cells by heparin and covalent antithrombin-heparin complex Academic Article
Initial Experience With Viabahn VBX as the Bridging Stent Graft for Branched and Fenestrated Endovascular Aneurysm Repair Academic Article
Initial and long-term treatment of deep venous thrombosis: recent clinical trials and their impact on patient management Academic Article
Initial treatment of venous thromboembolism Academic Article
Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey Academic Article
Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome Academic Article
Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): A cluster randomized trial of a computerized clinical decision support tool Academic Article
Integrating Clinical Decision Support into EMR and PHR: a Case Study Using Anticoagulation. Academic Article
Integrating Electronic Health Records in the Delivery of Optimized Anticoagulation Therapy Academic Article
Intensity and Quality of Warfarin Anticoagulation in Chinese Patients Academic Article
Intensity of Warfarin Coagulation in the Antiphospholipid Syndrome Academic Article
Intensive Initial Oral Anticoagulation and Shorter Heparin Treatment in Deep Vein Thrombosis Academic Article
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation Academic Article
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding Academic Article
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants Academic Article
International Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis Academic Article
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer Academic Article
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD) Academic Article
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries Academic Article
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism Academic Article
Intracardiac shunt with hypoxemia caused by right ventricular dysfunction following pericardiocentesis Academic Article
Intracerebral Hemorrhage Incidence, Mortality, and Association With Oral Anticoagulation Use Academic Article
Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema Academic Article
Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments Academic Article
Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran Academic Article
Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy Academic Article
Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. Academic Article
Intraoperative Heparin Flushes and Subsequent Acute Heparin-induced Thrombocytopenia Academic Article
Intravascular Targeting of a New Anticoagulant Heparin Compound Academic Article
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia Academic Article
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials Academic Article
Investigation of the Anticoagulant Mechanisms of a Covalent Antithrombin-Heparin Complex Academic Article
Investigations of the effectiveness of heparin variants as inhibitors of histones Academic Article
Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation? Academic Article
Is There a Role for Betrixaban to Prevent Stroke in Medically Ill Patients? Academic Article
Is aspirin safer than a direct oral anticoagulant for patients with atrial fibrillation at high risk of bleeding? Academic Article
Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis? Academic Article
Is the network meta-analysis (NETMA) bringing us closer to the truth? Insights from recent antithrombotic drug data Academic Article
Is the warfarin saga over? Academic Article
Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants? Academic Article
Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials Academic Article
Is there really misuse and abuse of dabigatran? Academic Article
Is venous thromboembolism a preventable cause of death? Academic Article
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48 Academic Article
Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy Academic Article
Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry Academic Article
Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery Academic Article
Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery Academic Article
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation Academic Article
LOWER-LIMB PHLEBOGRAPHY IN RECENT PARAPLEGIA AND TETRAPLEGIA Academic Article
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants Academic Article
Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation Academic Article
Laboratory Monitoring of Oral Vitamin K Anticoagulation Academic Article
Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants Academic Article
Laboratory diagnosis of heparin‐induced thrombocytopenia Academic Article
Laboratory measurement of the direct oral anticoagulants Academic Article
Laboratory monitoring of oral anticoagulant therapy. Academic Article
Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: A survey of North American specialized coagulation laboratories Academic Article
Laboratory testing for heparin-induced thrombocytopenia. Academic Article
Laboratory testing for heparin‐induced thrombocytopenia: a conceptual framework and implications for diagnosis Academic Article
Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials Academic Article
Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016–2017 Academic Article
Latest medical treatment strategies for venous thromboembolism Academic Article
Left Atrial Appendage Occlusion Academic Article
Left Atrial Appendage Occlusion Debate Revisited Academic Article
Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin Academic Article
Left Atrial Appendage Occlusion Eliminates the Need for Warfarin Academic Article
Left Atrial Appendage Occlusion Study II (LAAOS II) Academic Article
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke Academic Article
Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding Academic Article
Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials Academic Article
Less menorrhagia for women with VTE Academic Article
Letter Academic Article
Letter by de Vries et al Regarding Article “Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis” Academic Article
Letter to the Editor Academic Article
Letter to the editor Academic Article
Limitations of Administrative Data for Examining Secondary Atrial Fibrillation Academic Article
Limitations of conventional treatment options for heparin-induced thrombocytopenia. Academic Article
Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial Academic Article
Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran Academic Article
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis Academic Article
Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials Academic Article
Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction Academic Article
Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation? Conference Paper
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism Academic Article
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis Academic Article
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis Academic Article
Long-term Follow-up of the Implementation of a Venous Thromboembolism Prophylaxis Order Set on a Cardiology Ward: Still a Surprising Result? Academic Article
Long-term anticoagulant therapy in patients with venous thrombosis Academic Article
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation Academic Article
Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event Academic Article
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis Academic Article
Long‐term management of venous thromboembolism: is there a role for low‐intensity warfarin therapy? Academic Article
Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study Academic Article
Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study Academic Article
Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis Academic Article
Looking forward in the treatment of deep-vein thrombosis Academic Article
Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism Academic Article
Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery Academic Article
Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results Academic Article
Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS) Academic Article
Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism Conference Paper
Low Use of Oral Anticoagulant Prescribing for Secondary Stroke Prevention Academic Article
Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial. Academic Article
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Academic Article
Low molecular weight heparin and bleeding in patients with chronic renal failure Academic Article
Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels Academic Article
Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial Academic Article
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
Low molecular weight heparins and heparinoids Academic Article
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial Academic Article
Low-Intensity Adjusted-Dose Warfarin for the Prevention of Hemodialysis Catheter Failure Academic Article
Low-Intensity Warfarin Is Ineffective for the Prevention of PTFE Graft Failure in Patients on Hemodialysis Academic Article
Low-Intensity versus Conventional-Intensity Warfarin for Prevention of Recurrent Venous Thromboembolism Academic Article
Low-Molecular-Weight Heparin Did Not Differ from Placebo in Preventing Clinically Important Deep Venous Thrombosis After Surgical Repair of Leg Fracture Academic Article
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients Academic Article
Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin Academic Article
Low-Molecular-Weight Heparin as an Adjunct to Thrombolysis in ST Elevation Myocardial Infarction Academic Article
Low-Molecular-Weight Heparin for Anticoagulation During Continuous Venovenous Hemofiltration—Reply Academic Article
Low-Molecular-Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results Academic Article
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism Academic Article
Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients Academic Article
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer Academic Article
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial Academic Article
Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture Academic Article
Low-Molecular-Weight Heparins Academic Article
Low-Molecular-Weight Heparins in Acute Unstable Coronary Artery Disease – An Update Academic Article
Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin Academic Article
Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10 Academic Article
Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review Academic Article
Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin Academic Article
Low-dose warfarin in rehabilitating stroke survivors Academic Article
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants Academic Article
Low-molecular-weight heparin for the treatment of venous thromboembolism. Academic Article
Low-molecular-weight heparin in patients with chronic renal insufficiency Academic Article
Low-molecular-weight heparin in the treatment of pulmonary embolism. Academic Article
Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review Academic Article
Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial Academic Article
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis Academic Article
Low-molecular-weight heparin: from the bench to the orthopedic patient. Academic Article
Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review Academic Article
Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency Academic Article
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events. Academic Article
Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Academic Article
Low‐molecular‐weight heparins and heparinoids Academic Article
MAA868 locks factor XIa in a zymogen-like state Academic Article
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study Academic Article
Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials Academic Article
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation Academic Article
Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Academic Article
Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy Academic Article
Management Of Venous Thromboembolism: Optimization By Clinical Trials Academic Article
Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry Academic Article
Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin Academic Article
Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting Academic Article
Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery. Academic Article
Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor Academic Article
Management of Anticoagulation Around Pacemaker and Defibrillator Surgery Academic Article
Management of Anticoagulation Therapy in Patients With Thromboembolism in the Context of Renal Dysfunction Academic Article
Management of Anticoagulation before and after Elective Surgery Academic Article
Management of Antiphospholipid Antibody Syndrome Academic Article
Management of Bleeding Complications in the Anticoagulated Patient Academic Article
Management of Bleeding in Patients Receiving Conventional or New Anticoagulants Academic Article
Management of Deep Vein Thrombosis and Pulmonary Embolism Academic Article
Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists Academic Article
Management of Patients on Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Peri-Endoscopic Period: A Clinical Practice Guideline Dissemination Tool Academic Article
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy Academic Article
Management of Severe Mitral Stenosis During Pregnancy Academic Article
Management of Venous Thromboembolism: Present and Future Academic Article
Management of Venous Thrombosis in Cancer. Recent Developments in Diagnosis, Prevention, and Treatment Academic Article
Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health‐care providers Academic Article
Management of bleeding complications in patients with cancer on DOACs Academic Article
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease Academic Article
Management of bleeding with oral anticoagulants in patients with atrial fibrillation Academic Article
Management of cancer-associated upper extremity deep vein thrombosis with and without venous catheters at a tertiary care center Academic Article
Management of direct oral anticoagulant associated bleeding: Results of a multinational survey Academic Article
Management of heparin-induced thrombocytopenia Academic Article
Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban Academic Article
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses Academic Article
Management of heterotopic ossification and venous thromboembolism following acquired brain injury Academic Article
Management of intentional overdose of low-molecular-weight heparin Academic Article
Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report Academic Article
Management of patients who are receiving warfarin or a new oral anticoagulant and require urgent or emergency surgery Academic Article
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey Academic Article
Management of unstable coronary-artery disease Academic Article
Management of venous thromboembolism in cancer patients. Academic Article
Management of venous thromboembolism in patients with cancer: role of dalteparin Academic Article
Management strategies in unstable coronary artery disease-Current problems and future directions Academic Article
Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting Academic Article
Managing Novel Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Device Surgery: Canadian Survey Academic Article
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents Conference Paper
Managing challenging patients with venous thromboembolism: a practical, case-based approach Academic Article
Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery Academic Article
Managing oral anticoagulant therapy. Academic Article
Managing pain medications in long-term care: nurses' views Academic Article
Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents Academic Article
Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer Academic Article
Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides Academic Article
Maximum 24‐hour platelet count fall: Metric for improving the diagnosis of heparin‐induced thrombocytopenia among patients with intermediate probability 4Ts scores Academic Article
Measuring the anticoagulant effect of low molecular weight heparins in the critically ill. Academic Article
Mechanical valves Academic Article
Mechanism of Action and Monitoring of Anticoagulants Academic Article
Mechanism of Action and Pharmacology of Unfractionated Heparin Academic Article
Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo Academic Article
Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex Academic Article
Mechanisms and Clinical Manifestations of Cognitive Decline in Atrial Fibrillation Patients: Potential Implications for Preventing Dementia Academic Article
Mechanisms for the Anticoagulant Effects of Synthetic Antithrombins Academic Article
Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Academic Article
Mechanisms responsible for the failure of protamine  to inactivate low-molecular-weight heparin Academic Article
Medical device‐induced thrombosis: what causes it and how can we prevent it? Academic Article
Meeting the Unmet Needs in Anticoagulant Therapy Academic Article
Meta-Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study Academic Article
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency Academic Article
Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery Academic Article
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients Academic Article
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation Academic Article
Miconazole Oral Gel Potentiates Warfarin Anticoagulant Activity Academic Article
Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source Academic Article
Milestones in VTE treatment. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 2 Academic Article
Milvexian for the Prevention of Venous Thromboembolism Academic Article
Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35‐day cold‐storage regardless of leukoreduction timing Academic Article
Minimizing errors of omission: Behavioural rEenforcement of Heparin to Avert Venous Emboli: The BEHAVE Study* Academic Article
Modulation of Thrombin’s Procoagulant and Anticoagulant Properties Conference Paper
Molecular Basis for the Resistance of Fibrin-Bound Thrombin to Inactivation by Heparin/Serpin Complexes Academic Article
Monitoring Unfractionated Heparin (UFH) therapy: Which Anti Factor Xa assay is appropriate? Academic Article
Monitoring and reversal of direct oral anticoagulants Academic Article
Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH Academic Article
Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial Academic Article
Monitoring the anticoagulant effect after a massive rivaroxaban overdose Academic Article
More on Acutely Injured Patients Receiving Dabigatran Academic Article
Morphological analysis of microparticle generation in heparin-induced thrombocytopenia Academic Article
Mortality benefits of thromboprophylaxis Academic Article
Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate Academic Article
Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials Academic Article
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada Academic Article
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings Academic Article
Multicentre evaluation of 5B9, a monoclonal anti‐PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology Academic Article
Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia Academic Article
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation Academic Article
Mutation of Any Site of N-Linked Glycosylation Accelerates the In Vivo Clearance of Recombinant Rabbit Antithrombin Academic Article
Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Academic Article
NOACs for treatment of venous thromboembolism in clinical practice Academic Article
NOACs only for those who cannot tolerate a VKA: where is the evidence? Academic Article
Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis Academic Article
Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists Academic Article
Navigating the anticoagulant landscape in 2017 Academic Article
Need for a new paediatric post thrombotic sequelae outcome measure for non-extremity thrombosis Academic Article
Neonatal Aortic Thrombosis: A Comprehensive Review Academic Article
Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia Academic Article
New Anticoagulant Drugs Academic Article
New Anticoagulant Strategies Academic Article
New Anticoagulant Therapy Academic Article
New Anticoagulants Academic Article
New Anticoagulants Academic Article
New Anticoagulants Academic Article
New Anticoagulants for Atrial Fibrillation Academic Article
New Anticoagulants for Atrial Fibrillation: The Beginning of a A New Era in Stroke Prevention Academic Article
New Anticoagulants for Treatment of Venous Thromboembolism Academic Article
New Anticoagulants for Treatment of Venous Thromboembolism Academic Article
New Anticoagulants for the Prevention of Thromboembolism Academic Article
New Antithrombotic Agents Academic Article
New Antithrombotic Drugs Academic Article
New Antithrombotic Drugs Academic Article
New Antithrombotic Drugs: Beyond Aspirin and Heparin Academic Article
New Antithrombotic Drugs: Potential for Use in Oncology Academic Article
New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia Academic Article
New Concepts in Coagulation Academic Article
New Frontiers in the Management of Unstable Coronary Artery Disease Academic Article
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes Academic Article
New anticoagulant drugs. Academic Article
New anticoagulant strategies. Academic Article
New anticoagulants Academic Article
New anticoagulants Conference Paper
New anticoagulants in atrial fibrillation management Conference Paper
New anticoagulants. Academic Article
New anticoagulants: Moving beyond the direct oral anticoagulants Academic Article
New anticoagulants: an update. Academic Article
New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin Academic Article
New antithrombotic agents—insights from clinical trials Academic Article
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF Academic Article
New aspects on treatment modalities for thromboembolic episodes Academic Article
New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism Academic Article
New developments in anticoagulants: Past, present and future Academic Article
New oral anticoagulant agents – general features and outcomes in subsets of patients Academic Article
New oral anticoagulants and oculoplastic surgery Academic Article
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions Academic Article
New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty Academic Article
New oral anticoagulants in atrial fibrillation Academic Article
New oral anticoagulants in development Academic Article
New oral anticoagulants in elderly patients Academic Article
New oral anticoagulants versus vitamin K antagonists for treatment of acute venous thromboembolism: do they really increase the incidence of myocardial infarction? Academic Article
New oral anticoagulants: A view from the laboratory Academic Article
New oral anticoagulants: not quite there yet Academic Article
New oral anticoagulants: which one should my patient use? Academic Article
New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010 Academic Article
New-Onset Atrial Fibrillation Academic Article
Newer Anticoagulants in Critically Ill Patients Academic Article
Newly Identified Events in the RE-LY Trial Academic Article
Non-OO blood type influences the risk of recurrent venous thromboembolism Academic Article
Non-Vitamin K Antagonist Oral Anticoagulants Academic Article
Non-injection-site necrotic skin lesions complicating postoperative heparin thromboprophylaxis Academic Article
Non-variceal upper gastrointestinal bleeding Academic Article
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel Academic Article
Nonadherence with INR Monitoring and Anticoagulant Complications Academic Article
Nonbleeding complications of unfractionated and low-molecular weight heparins. Academic Article
Nonhemorrhagic Complications of Anticoagulant Therapy Academic Article
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Academic Article
Nonleg Venous Thrombosis in Critically Ill Adults Conference Paper
Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy. Academic Article
Nontreatment of deep vein thrombosis. Academic Article
Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment Academic Article
Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study Academic Article
North American Thrombosis Forum, AF Action Initiative Consensus Document Academic Article
North American and British guidelines for anti-thrombotic therapy: are we reaching consensus? Conference Paper
Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study Academic Article
Novel Oral Anticoagulants for Atrial Fibrillation Academic Article
Novel Oral Anticoagulants: A Focused Review for Stroke Physicians Academic Article
Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism Academic Article
Novel anticoagulant agents: introduction Academic Article
Novel antithrombotic strategies for treatment of venous thromboembolism Academic Article
Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants Academic Article
Novel oral anticoagulants and reversal agents: Considerations for clinical development Academic Article
Novel oral anticoagulants in gastroenterology practice Academic Article
Novel oral anticoagulants in secondary prevention of stroke Academic Article
Novel paediatric anticoagulants: a review of the current literature Academic Article
Observations in anticoagulant and thrombolytic therapy in pulmonary embolism Academic Article
Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia Academic Article
Optical Densities Reduce Odds of Heparin-induced Thrombocytopenia Over-diagnosis Academic Article
Optimal Anticoagulation for Pregnant Women with Mechanical Heart Valves Academic Article
Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis Academic Article
Optimal Duration of Anticoagulant Therapy Academic Article
Optimal Duration of Oral Anticoagulant Therapy in Venous Thromboembolism Academic Article
Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis Academic Article
Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage Academic Article
Optimal reversal of vitamin K antagonists Academic Article
Optimal therapeutic range for oral anticoagulants. Academic Article
Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeons Academic Article
Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding Academic Article
Optimal treatment duration of venous thrombosis Academic Article
Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants Academic Article
Optimum Use of Anticoagulants in Pregnancy Academic Article
Oral Anticoagulant Drugs Academic Article
Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms Academic Article
Oral Anticoagulant Therapy Academic Article
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis Academic Article
Oral Anticoagulant Therapy in Patients with Coronary Artery Disease Academic Article
Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Cancer Academic Article
Oral Anticoagulant Use in Patients With Chronic Kidney Disease: How to Choose, and the Importance of Empiric Human Data Academic Article
Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis Academic Article
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease Academic Article
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation Academic Article
Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in Academic Article
Oral Anticoagulation Treatment in the Elderly Academic Article
Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry* Academic Article
Oral Apixaban for the Treatment of Acute Venous Thromboembolism Academic Article
Oral Direct Factor Xa Inhibitors Academic Article
Oral Rivaroxaban for Symptomatic Venous Thromboembolism Academic Article
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism Academic Article
Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy Academic Article
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin Academic Article
Oral anticoagulant dosing, administration, and storage: a cross-sectional survey of Canadian health care providers Academic Article
Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts Academic Article
Oral anticoagulant therapy. Urgent need for standardization. Academic Article
Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives Academic Article
Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF Academic Article
Oral anticoagulants and non-cardioembolic stroke prevention Academic Article
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks Academic Article
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks Academic Article
Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease Academic Article
Oral anticoagulants in patients with coronary artery disease Academic Article
Oral anticoagulants in patients with coronary artery disease: an inexpensive and effective strategy Academic Article
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks Academic Article
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range Academic Article
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Academic Article
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Academic Article
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Academic Article
Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis Academic Article
Oral anticoagulation for prolonging survival in patients with cancer Academic Article
Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group Academic Article
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Oral anticoagulation in venous thromboembolism: decisions based on more than mere feelings Academic Article
Oral anticoagulation may prolong survival of a subgroup of patients with cancer: a cochrane systematic review Academic Article
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial Academic Article
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis Academic Article
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement Academic Article
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement Academic Article
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10 Academic Article
Oral vitamin K for warfarin-associated coagulopathy. Academic Article
Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin. Academic Article
Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases Academic Article
Oral-anticoagulant-related intracerebral hemorrhage Academic Article
Orally Active Direct Thrombin Inhibitors Academic Article
Organ Distribution of Fibrin in Disseminated Intravascular Coagulation Academic Article
Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials Academic Article
Otamixaban in acute coronary syndromes Academic Article
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation Academic Article
Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study Academic Article
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy Academic Article
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF Academic Article
Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation Academic Article
Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours Academic Article
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study Academic Article
Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concerns Academic Article
Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation Academic Article
Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction Academic Article
Overview of the New Oral Anticoagulants Academic Article
PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients Academic Article
PRE‐OPERATIVE FACTOR Xa–TFPI AND POST‐OPERATIVE VENOUS THROMBOSIS Academic Article
PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma Academic Article
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation Academic Article
Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral Anticoagulation Academic Article
Pancreatic pseudocyst: heparin-induced haemorrhage through the ampulla of Vater. Academic Article
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial Academic Article
Paper-based dosing algorithms for maintenance of warfarin anticoagulation Academic Article
Parenteral Anticoagulants Academic Article
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II) Academic Article
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation Academic Article
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review Academic Article
Paroxysmal Atrial Fibrillation in a Patient on Hemodialysis Academic Article
Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence Academic Article
Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline Academic Article
Patient Self-Monitoring of Oral Anticoagulant Therapy Academic Article
Patient education about anticoagulant medication: Is narrative evidence or statistical evidence more effective? Academic Article
Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial Academic Article
Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment Academic Article
Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines Academic Article
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism Academic Article
Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences Academic Article
Patient-reported health preferences of anticoagulant-related outcomes Academic Article
Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism Academic Article
Patients' perspectives on taking warfarin: qualitative study in family practice Academic Article
Pediatric superior vena cava syndrome: An evidence-based systematic review of the literature Academic Article
Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management Academic Article
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation Academic Article
Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL ® HIT-Ab (PF4-H) ] for the diagnosis of immune heparin-induced thrombocytopenia Academic Article
Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial Academic Article
Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack Academic Article
Perioperative Anticoagulation for Patients with Mechanical Heart Valves: A Survey of Current Practice Academic Article
Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians Academic Article
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation Academic Article
Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry) Academic Article
Perioperative Management of Antithrombotic Therapy Academic Article
Perioperative Management of Oral Anticoagulation Academic Article
Perioperative Management of Oral Anticoagulation Academic Article
Perioperative Management of Patients Having Noncardiac Surgery Who Are Receiving Anticoagulant or Antiplatelet Therapy: An Evidence-Based but Practical Approach Academic Article
Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach Academic Article
Perioperative Management of Patients Receiving Oral Anticoagulants Academic Article
Perioperative Management of Patients Receiving Oral Anticoagulants Academic Article
Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question Academic Article
Perioperative Management of the Direct Oral Anticoagulants Academic Article
Perioperative anticoagulant management in patients with atrial fibrillation: practical implications of recent clinical trials Academic Article
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide Academic Article
Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey. Academic Article
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians Academic Article
Perioperative anticoagulation—are we at 'a bridge too far'? Academic Article
Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines Academic Article
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure Academic Article
Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation Academic Article
Perioperative management of anticoagulant and antiplatelet therapy Academic Article
Perioperative management of antithrombotic therapy: a case-based narrative review Academic Article
Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach Academic Article
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin Academic Article
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists Academic Article
Periprocedural Management of Direct Oral Anticoagulants Academic Article
Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation Academic Article
Periprocedural Management of Oral Anticoagulation Academic Article
Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants Academic Article
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
Periprocedural interruption of anticoagulation in patients with cancer‐associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes Academic Article
Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery Academic Article
Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH Academic Article
Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation Academic Article
Pharmacogenetics of Stroke Academic Article
Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran Academic Article
Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art Academic Article
Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis Academic Article
Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients Conference Paper
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients Academic Article
Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis Academic Article
Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management Academic Article
Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism Academic Article
Pharmacological Actions of Sulodexide Academic Article
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research Academic Article
Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis Academic Article
Pharmacology and Clinical Potential of Direct Thrombin Inhibitors Academic Article
Pharmacology and Management of the Vitamin K Antagonists Academic Article
Pharmacology of the low-molecular-weight heparins Academic Article
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis Academic Article
Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial Academic Article
Pharmacoprophylaxis for Venous Thromboembolism in Spinal Surgery: A Systematic Review and Meta-analysis Academic Article
Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome Academic Article
Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery Academic Article
Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. Academic Article
Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory Academic Article
Placental transport of low molecular weight heparin in the pregnant sheep Academic Article
Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review Academic Article
Platelet Activation Testing for Heparin-Induced Thrombocytopenia Antibodies Academic Article
Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review Academic Article
Platelet electrophoresis: effect of defibrination by ancrod (Arvin) Academic Article
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay Academic Article
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease Academic Article
Platelet‐activating immune complexes identified in critically ill COVID‐19 patients suspected of heparin‐induced thrombocytopenia Academic Article
Pneumatic Compression in Venous Thromboprophylaxis Academic Article
Polish guidelines for the prevention and treatment of venous thromboembolism 2009 update Academic Article
Polypeptide-Polysaccharide Conjugates Produced by Spontaneous Non-Enzymatic Glycation Academic Article
Polyurethane modified with an antithrombin-heparin complex via polyethylene oxide linker/spacers: Influence of PEO molecular weight and PEO-ATH bond on catalytic and direct anticoagulant functions Academic Article
Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment? Academic Article
Posthospital discharge venous thromboembolism prophylaxis among colorectal and hepatobiliary surgeons: A practice survey Academic Article
Postoperative Low-Molecular-Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators Academic Article
Postoperative atrial fibrillation in non‐cardiac and cardiac surgery: an overview Academic Article
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial Academic Article
Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months Academic Article
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial Academic Article
Potential antidotes for reversal of old and new oral anticoagulants Academic Article
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation Academic Article
Potential of new anticoagulants in patients with cancer Academic Article
Practical aspects of new oral anticoagulant use in atrial fibrillation Academic Article
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk Academic Article
Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure Conference Paper
Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban Academic Article
Practical management of coagulopathy associated with warfarin. Academic Article
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation Academic Article
Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung Academic Article
Pre-Screening for Atrial Fibrillation Using the Electronic Health Record Academic Article
Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy Academic Article
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH) Academic Article
Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation Academic Article
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Academic Article
Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol Academic Article
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis Academic Article
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF Academic Article
Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial Academic Article
Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA) Academic Article
Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol Academic Article
Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial Academic Article
Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency Academic Article
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure Academic Article
Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis Academic Article
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001 Academic Article
Predictors, Prognosis, and Management of New Clinically Important Atrial Fibrillation After Noncardiac Surgery: A Prospective Cohort Study Academic Article
Preface Academic Article
Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making Academic Article
Pregnancy, Heparin and Osteoporosis Academic Article
Pregnancy-Associated Venous Thromboembolism: Prevention and Treatment Academic Article
Pretreatment of Rabbits With Either Hirudin, Ancrod, or Warfarin Significantly Reduces the Immediate Uptake of Fibrinogen and Platelets by the Deendothelialized Aorta Wall After Balloon-Catheter Injury In Vivo Academic Article
Prevalence and Management of Atrial Thrombi in Patients With Atrial Fibrillation Before Pulmonary Vein Isolation Academic Article
Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE Academic Article
Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study Academic Article
Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registries Academic Article
Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation Academic Article
Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran Academic Article
Preventing Thromboembolism in Patients with Prosthetic Heart Valves Academic Article
Preventing and managing bleeding complications in anticoagulated patients: A case based approach Academic Article
Preventing stroke in atrial fibrillation: why are so many eligible patients not receiving anticoagulant therapy? Academic Article
Preventing thrombophilia-related complications of pregnancy Academic Article
Preventing thrombophilia-related complications of pregnancy: an update Academic Article
Prevention and Treatment of Hormone-Associated Venous Thromboembolism: A Patient Management Approach Academic Article
Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey. Academic Article
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention Academic Article
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment Academic Article
Prevention and treatment of venous thromboembolism during pregnancy Academic Article
Prevention and treatment of venous thromboembolism in the elderly patient. Academic Article
Prevention of Postthrombotic Syndrome Academic Article
Prevention of Thromboembolic Events After Bioprosthetic Aortic Valve Replacement Academic Article
Prevention of Thrombosis in Ambulatory Patients With Cancer Academic Article
Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy Academic Article
Prevention of Vascular Events in Patients with Atrial Fibrillation: Academic Article
Prevention of Venous Thromboembolism Academic Article
Prevention of Venous Thromboembolism Academic Article
Prevention of Venous Thromboembolism Academic Article
Prevention of Venous Thromboembolism After Hip or Knee Arthroplasty Academic Article
Prevention of Venous Thromboembolism Among Hospitalized Medical Patients Academic Article
Prevention of Venous Thrombosis After Elective Hip Surgery Academic Article
Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin Academic Article
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone Academic Article
Prevention of deep venous thrombosis. Academic Article
Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review Academic Article
Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation Academic Article
Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study Academic Article
Prevention of venous thromboembolism in critically ill surgery patients: A cross-sectional study Academic Article
Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions Academic Article
Prevention of venous thromboembolism in medical cancer patients: Guidance or guideline? Academic Article
Prevention of venous thromboembolism in medical patients with enoxaparin Academic Article
Prevention of venous thromboembolism in medically ill patients: a clinical update Academic Article
Prevention of venous thrombosis after electrophysiology procedures: a survey of national practice Academic Article
Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures. Academic Article
Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. Academic Article
Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke Academic Article
Principles and practice of coronary thrombolysis and conjunctive treatment Academic Article
Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants Academic Article
Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation” Academic Article
Probable regulation of factor VIIa–tissue factor and prothrombinase by factor Xa–TFPI and TFPI in vivo Academic Article
Proceedings of the 12th national conference on anticoagulant therapy Academic Article
Procoagulants for management of bleeding with the new oral anticoagulants Academic Article
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation Academic Article
Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients—A Systematic Review and Meta-Analysis Academic Article
Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study) Academic Article
Prognostic differences between atrial fibrillation and atrial flutter Academic Article
Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran Academic Article
Prognostic importance of preoperative anti-PF4/heparin antibodies in patients undergoing cardiac surgery Academic Article
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis Academic Article
Progressive thrombocytopenia after cardiac surgery in a 67-year-old man Academic Article
Prolonged Antithrombin Activity of Low-Molecular-Weight Heparins Academic Article
Prolonged Cardiac Monitoring and Stroke Recurrence Academic Article
Prolonged in vivo anticoagulant activity of a hirudin–albumin fusion protein secreted from Pichia pastoris Academic Article
Promoting the health of senior citizens. Academic Article
Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle> Academic Article
Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence‑based and practical approach Academic Article
Prophylaxis against venous thromboembolism in neurointensive care patients: Survey of Canadian practice Academic Article
Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline. Academic Article
Prophylaxis extension for venous thromboembolism after major abdominal and pelvic surgery for cancer (prevent): Quality improvement transitioned into a cohort study Academic Article
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study Academic Article
Prophylaxis of venous thromboembolism. An overview. Academic Article
Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation Academic Article
Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia Academic Article
Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients Academic Article
Prosthetic Heart Valve Thrombosis Academic Article
Protamine (heparin)‐induced thrombocytopenia: a review of the serological and clinical features associated with anti‐protamine/heparin antibodies Academic Article
Protein C Assay Performance Academic Article
Protein Engineering Thrombin for Optimal Specificity and Potency of Anticoagulant Activity in Vivo Academic Article
Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non–vitamin K Anticoagulant Reversal Academic Article
Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate Academic Article
Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis Academic Article
Prothrombotic genetic risk factors and heparin-induced thrombocytopenia Academic Article
Protocol implementation for venous thromboembolism prophylaxis: a before-and-after study in medical and surgical patients Academic Article
Präoperative Bewertung des Blutungs- und Thromboseembolierisikos Academic Article
Prévention des complications vasculaires après ischémie cérébrale d'origine artérielle. Étude ESPRIT: anticoagulation modérée, association aspirine-dipyridamole ou aspirine seule ? Academic Article
Pseudothrombocytopenia Due to Platelet Aggregation and Degranulation in Blood Collected in EDTA Academic Article
Pulmonary Embolism With Duplicated Inferior Vena Cava Academic Article
Pulmonary Embolism in Medical-Surgical Critically Ill Patients Academic Article
Pulmonary Embolism in Pregnancy Academic Article
Pulmonary Embolism in the Elderly Academic Article
Putting heparin into perspective: its history and the evolution of its use during percutaneous coronary interventions. Academic Article
Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm Academic Article
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry Academic Article
Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review Academic Article
Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study Academic Article
Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study Group. Academic Article
Questioning the Treatment of Venous Thromboembolism Academic Article
RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT Academic Article
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate Academic Article
Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol Academic Article
Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy Academic Article
Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation Academic Article
Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism Academic Article
Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer Academic Article
Randomized Trial of Warfarin Nomograms Academic Article
Randomized Trial of Warfarin Nomograms Academic Article
Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis) Academic Article
Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation Academic Article
Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis Academic Article
Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study Academic Article
Randomized trial of warfarin nomograms. Academic Article
Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention Academic Article
Randomized, Controlled Trial of Individualized Heparin and Protamine Management in Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass Academic Article
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients Academic Article
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments] Academic Article
Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study Academic Article
Rapid reversal of haematoma expansion associated with vitamin K antagonists Academic Article
Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation Academic Article
Rates of hemorrhage during warfarin therapy for atrial fibrillation Academic Article
Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding Academic Article
Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran Academic Article
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery Academic Article
Rationale and design of a Global Rheumatic Heart Disease Registry: The REMEDY study Academic Article
Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis Academic Article
Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial Academic Article
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial Academic Article
Re: Anticoagulation and Antiplatelet Therapy in Urological Practice: ICUD/AUA Review Paper: D. J. Culkin, E. J. Exaire, D. Green, M. S. Soloway, A. J. Gross, M. R. Desai, J. R. White and D. J. Lightner J Urol 2014; 192: 1026-1034 Academic Article
Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702. Academic Article
Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial Academic Article
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens Academic Article
Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial Academic Article
Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent Academic Article
Recent advances in understanding, diagnosing and treating venous thrombosis Academic Article
Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins Academic Article
Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update Academic Article
Recommendations for developing uniform laboratory monitoring of heparinoid anticoagulants in children Academic Article
Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH Academic Article
Recommendations from the ICM-VTE: Oncology Academic Article
Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and meta‐analysis Academic Article
Recurrent Venous Thrombosis and Heparin Therapy Academic Article
Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta‐analysis Academic Article
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis Academic Article
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study Academic Article
Reduced-Intensity Anticoagulation for Mechanical Aortic Valve Prostheses Academic Article
Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism Academic Article
Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial Academic Article
Reduced‐dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta‐analysis—Response to Commentary Academic Article
Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis Academic Article
Reducing the risk of recurrent stroke in patients with AF Academic Article
Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis Academic Article
Refining Risk Prediction for Recurrent Venous Thromboembolism: Can We Do Better? Academic Article
Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure Academic Article
Relationship Between Thromboembolic Complications and Intensity of Treatment During Long-Term Prophylaxis with Oral Anticoagulants Following DVT Academic Article
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Academic Article
Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis Academic Article
Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin Academic Article
Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin Academic Article
Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio Academic Article
Reply to Left Atrial Appendage Closure During Cardiac Surgery for Atrial Fibrillation: A Meta-Analysis Academic Article
Reply to Standard Versus Higher Intensity Anticoagulation for Patients With Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism Academic Article
Reply to Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care Academic Article
Reply to Xu—Oral Anticoagulants, Health Technology Assessment, and Health Policy Academic Article
Reply: Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis? Academic Article
Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban Academic Article
Research agenda: venous thromboembolism in medical-surgical critically ill patients Academic Article
Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation Academic Article
Residual Vein Thrombosis and D-Dimer for Optimizing Duration of Anticoagulation in Idiopathic Deep Vein Thrombosis Academic Article
Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study Academic Article
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study Academic Article
Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study Academic Article
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study Academic Article
Resolving Concerns With the Newer Oral Anticoagulant Medications Academic Article
Resource Use and Costs of Treatment With Anticoagulation and Antiplatelet Agents: Results of the WATCH Trial Economic Evaluation Academic Article
Response by Chan and Weitz to Letter Regarding Article, “Antithrombotic Agents: New Directions in Antithrombotic Therapy” Academic Article
Response by Weitz and Eikelboom to Letter Regarding Article, “Urgent Need to Measure Effects of Direct Oral Anticoagulants” Academic Article
Response to Letter Regarding Article, “Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy” Academic Article
Response to Letter Regarding Article, “Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study” Academic Article
Response to letter: non‐vitamin‐K oral anticoagulants may not significantly reduce the risk of fatal or disabling stroke compared with warfarin Academic Article
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. Academic Article
Response to “Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban” Academic Article
Response. Academic Article
Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality Academic Article
Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage Academic Article
Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis Academic Article
Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management Academic Article
Reversal agents for non-vitamin K antagonist oral anticoagulants Academic Article
Reversal of Direct Oral Anticoagulants: Current Status and Future Directions Academic Article
Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies Academic Article
Reversal of Warfarin Academic Article
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum Academic Article
Reversal of direct oral anticoagulants: a practical approach Academic Article
Reversal of novel oral anticoagulants in patients with major bleeding Academic Article
Reversal of target-specific oral anticoagulants Academic Article
Reversal of target-specific oral anticoagulants Academic Article
Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1 Academic Article
Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice Academic Article
Reversible endotension associated with excessive warfarin anticoagulation Academic Article
Reversing Anticoagulant Therapy Academic Article
Reversing anticoagulants both old and new. Academic Article
Review of enoxaparin and its clinical applications in venous and arterial thromboembolism Academic Article
Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding Academic Article
Review: New oral anticoagulants increase GI bleeding in venous thrombosis and ACS Academic Article
Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation Academic Article
Review: Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit Academic Article
Reviparin in acute myocardial infarction. Academic Article
Right-sided endocarditis secondary to a peritoneovenous shunt Academic Article
Risk Assessment and Primary VTE Prevention in the Cancer Patient Academic Article
Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness Academic Article
Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit) Academic Article
Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review Academic Article
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial Academic Article
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis Academic Article
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation Academic Article
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban Academic Article
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Academic Article
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment Academic Article
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation Academic Article
Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound Academic Article
Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism Academic Article
Risk of Haemorrhage Associated with Long Term Anticoagulant Therapy Academic Article
Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding Academic Article
Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin Academic Article
Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal Academic Article
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis Academic Article
Risk of intracranial hemorrhage between different direct oral anticoagulants in older patients seen in the emergency department with a head injury: A population-based cohort study Academic Article
Risk of mortality and stroke after atrial fibrillation – Authors' reply Academic Article
Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study Academic Article
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis Academic Article
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode Academic Article
Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting Academic Article
Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism Academic Article
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage Academic Article
Risks and Benefits of Anticoagulant Therapy Academic Article
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk Academic Article
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials Academic Article
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry Academic Article
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial Academic Article
Risks to the Fetus of Anticoagulant Therapy During Pregnancy Academic Article
Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios Academic Article
Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro Academic Article
Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography Academic Article
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial Academic Article
Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions Academic Article
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older Academic Article
Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial Academic Article
Rivaroxaban for the prevention and treatment of venous thromboembolism Academic Article
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation Academic Article
Rivaroxaban for treatment of suspected or confirmed heparin‐induced thrombocytopenia study Academic Article
Rivaroxaban in Orthopedic Surgery — A Change of Paradigm? Academic Article
Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation Academic Article
Rivaroxaban in Stable Cardiovascular Disease Academic Article
Rivaroxaban in treatment refractory heparin-induced thrombocytopenia Academic Article
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty Academic Article
Rivaroxaban versus enoxaparin after total knee arthroplasty Academic Article
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial Academic Article
Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study Academic Article
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease Academic Article
Role of antithrombotic therapy in atrial fibrillation. Academic Article
Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients Academic Article
Role of oral anticoagulation in management of atrial fibrillation Academic Article
Routine home treatment of deep vein thrombosis Academic Article
SR123781A: A New Once-Daily Synthetic Oligosaccharide Anticoagulant for Thromboprophylaxis After Total Hip Replacement Surgery Academic Article
Safe bridging to warfarin in heparin-induced thrombocytopenia Academic Article
Safer anticoagulant therapy after heart valve replacement Academic Article
Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis Academic Article
Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Failure: A Meta-analysis of Randomized Trials Academic Article
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism Academic Article
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study Academic Article
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE) Academic Article
Safety of Uninterrupted Anticoagulation in Patients Requiring Elective Coronary Angiography With or Without Percutaneous Coronary Intervention Academic Article
Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism Academic Article
Safety of anticoagulants in children with arterial ischemic stroke Academic Article
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists Academic Article
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Academic Article
Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging Academic Article
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk Academic Article
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 Academic Article
Scoring systems for heparin-induced thrombocytopenia (HIT): Whither now? Academic Article
Screening for Atrial Fibrillation in the Older Population Academic Article
Screening for undiagnosed atrial fibrillation Academic Article
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation Academic Article
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran Academic Article
Secondary prevention of venous thromboembolism Academic Article
Sekundärprävention nach ischämischem zerebralem Insult Academic Article
Selection Bias, Orthopaedic Style Academic Article
Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis Academic Article
Selective cleavage of heparin using aqueous 2-hydroxypyridine: Production of an aldose-terminating fragment with high anticoagulant activity Academic Article
Selective factor Xa inhibition for thromboprophylaxis Academic Article
Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review Academic Article
Serial measurement of interleukin‐6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE‐LY trials Academic Article
Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative: HIT or not HIT ? Academic Article
Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE Academic Article
Setting a standard for venous thromboembolism prophylaxis Academic Article
Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen? Academic Article
Short report: managing anticoagulation. Comparison of results at three primary care centres. Academic Article
Short- and Long-term Health Care Resource Utilization and Costs Following Intracerebral Hemorrhage Academic Article
Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement Academic Article
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial Academic Article
Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis Academic Article
Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated? Academic Article
Should adult patients be routinely tested for heritable thrombophilia after an episode of venous thromboembolism? Academic Article
Should the presence of an antiphospholipid antibody affect the duration of anticoagulant treatment in patients with venous thromboembolism? Academic Article
Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation Academic Article
Should vitamin K be administered when HIT is diagnosed after administration of coumarin? Academic Article
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Academic Article
Side-Effects of COVID-19 on Patient Care: An INR Story Academic Article
Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation Academic Article
Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up Academic Article
Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin Academic Article
Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range Academic Article
Small intestinal bacterial overgrowth and warfarin dose requirement variability Academic Article
So, Does Low-Molecular-Weight Heparin Cause Less Heparin-Induced Thrombocytopenia Than Unfractionated Heparin or Not? Academic Article
Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study Academic Article
Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective Academic Article
Special series on challenging anticoagulation cases: Experience counts when guidelines fall short Academic Article
Specific antidotes for bleeding associated with direct oral anticoagulants Academic Article
Splanchnic vein thrombosis: what are the long-term risks? Academic Article
Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia Academic Article
Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder Academic Article
Spontaneous neonatal arterial thromboembolism Academic Article
Standardized Bleeding Definitions for Cardiovascular Clinical Trials Academic Article
State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism Academic Article
Strategies for development of novel antithrombotics: modulating thrombin's procoagulant and anticoagulant properties Academic Article
Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial Academic Article
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial Academic Article
Stroke Prenotification Is Associated with Shorter Treatment Times for Warfarin-Associated Intracerebral Hemorrhage Academic Article
Stroke Prevention in Atrial Fibrillation Academic Article
Stroke Prevention in Atrial Fibrillation Academic Article
Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease Academic Article
Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Academic Article
Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification? Academic Article
Stroke and Thromboprophylaxis in the Era of COVID-19 Academic Article
Stroke prevention for patients with atrial fibrillation: values and preferences of Canadian emergency medicine trainees Academic Article
Stroke prevention in atrial fibrillation: Closing the gap Academic Article
Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes Academic Article
Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation Academic Article
Stroke prevention in older adults with atrial fibrillation Academic Article
Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry Academic Article
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease Academic Article
Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program Academic Article
Structural and Binding Effects of Chemical Modifications on Thrombin Binding Aptamer (TBA) Academic Article
Structure and function of a perioperative anticoagulation management clinic Academic Article
Studies of the antiâplatelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens Academic Article
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective Academic Article
Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin Academic Article
Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose Academic Article
Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial Academic Article
Sub‐segmental pulmonary embolism in three academic teaching hospitals: a review of management and outcomes Academic Article
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials Academic Article
Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis Academic Article
Surface modification with an antithrombin–heparin complex for anticoagulation: Studies on a model surface with gold as substrate Academic Article
Surgical exposure of the carotid artery for endovascular interventional procedures Academic Article
Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves. Academic Article
Survey of pharmacologic thromboprophylaxis in critically ill children* Academic Article
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update Academic Article
Switching Patients From Blinded Study Drug to Warfarin at the End of the ENGAGE AF–TIMI 48 Trial Academic Article
Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis Academic Article
Symptomatic venous thromboembolism after orthognathic operations: An audit Academic Article
Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease Academic Article
Systematic Overview of Warfarin and Its Drug and Food Interactions Academic Article
Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants Academic Article
Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism Academic Article
Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer Academic Article
Systematic lower limb phlebography in acute spinal cord injury in 147 patients Academic Article
Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis Academic Article
Systematic review of anticoagulant treatment of catheter-related thrombosis Academic Article
Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale Academic Article
THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY Academic Article
Tailoring warfarin induction doses to reflect individual and disease-specific factors Academic Article
Temporal Aspects of Heparin-Induced Thrombocytopenia Academic Article
Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Academic Article
Testing for Heparin-Induced Thrombocytopenia Antibodies Academic Article
The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal Academic Article
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation Academic Article
The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients Academic Article
The APTT Response of Pregnant Plasma to Unfractionated Heparin Academic Article
The Additive Effect of Low Molecular Weight Heparins on Thrombin Inhibition by Dermatan Sulfate Academic Article
The Approach to Heparin-Induced Thrombocytopenia Academic Article
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy Academic Article
The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe? Academic Article
The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED) Academic Article
The Clinical Utility of a Rapid Bedside D-dimer Assay for Screening of Deep Vein Thrombosis following Orthopaedic Surgery Academic Article
The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty Academic Article
The Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation Academic Article
The Diagnosis and Management of Ovarian Hyperstimulation Syndrome Academic Article
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism Academic Article
The Duration of Oral Anticoagulation after Deep Vein Thrombosis Academic Article
The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes Academic Article
The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial Academic Article
The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density Academic Article
The Efficacy and Safety of Heparin in Patients With Sepsis Academic Article
The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia Academic Article
The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population Academic Article
The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations Academic Article
The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion Academic Article
The Incidence of Symptomatic Venous Thromboembolism After Enoxaparin Prophylaxis in Lower Extremity Arthroplasty Academic Article
The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin<subtitle>A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty</subtitle> Conference Paper
The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis Conference Paper
The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War? Academic Article
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE Academic Article
The New Canadian Cardiovascular Society Algorithm for Antithrombotic Therapy of Atrial Fibrillation Is Appropriately Based on Current Epidemiologic Data Academic Article
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations Academic Article
The Occurrence of Subsequent Malignancy in Patients Presenting with Deep Vein Thrombosis: Results from a Historical Cohort Study Academic Article
The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial Academic Article
The Optimal Duration of Anticoagulant Therapy for Venous Thrombosis Academic Article
The Oral Thrombin Inhibitor Dabigatran: Strengths and Weaknesses Academic Article
The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina Academic Article
The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia Academic Article
The Pathophysiology of Heparin-Induced Thrombocytopenia Academic Article
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale Academic Article
The Pharmacology and Management of the Vitamin K Antagonists Academic Article
The Real Decoy Academic Article
The Risk Factors for Thromboembolism in Nonvalvular Atrial Fibrillation and CHADS2 Scoring in Japan Academic Article
The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism Academic Article
The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy Academic Article
The Role for Optical Density in Heparin-Induced Thrombocytopenia Academic Article
The Role of Ximelagatran in the Treatment of Venous Thromboembolism Academic Article
The Saudi Clinical Practice Guideline for the treatment of venous thromboembolism: Outpatient versus inpatient management Academic Article
The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers Academic Article
The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients Academic Article
The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants Academic Article
The Ten Most Commonly Asked Questions about Chronic Anticoagulant Use in Cardiology Academic Article
The United States Food and Drugs Administration Approves a Generic Enoxaparin Academic Article
The Vagus Nerve: A Tonic Inhibitory Influence Associated With Inflammatory Bowel Disease in a Murine Model Academic Article
The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics Academic Article
The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal Academic Article
The activated clotting time in cardiac surgery: should Celite or kaolin be used? Academic Article
The anticoagulant action of puff adder (B. arietans) venom. Academic Article
The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation Academic Article
The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study Academic Article
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events Academic Article
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation Academic Article
The beginning of the end of warfarin? Academic Article
The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem Academic Article
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients Academic Article
The clinical impact of bleeding during oral anticoagulant therapy Academic Article
The conundrum of resuming anticoagulant therapy after intracerebral bleeding: In whom, when, and how? Academic Article
The cost‐effectiveness of computer‐assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study Academic Article
The design of venous thromboembolism prophylaxis trials: Fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery Academic Article
The detection and treatment of subclinical atrial fibrillation: evaluating the IMPACT of a comprehensive strategy based on remote arrhythmia monitoring Academic Article
The diagnosis and prevention of post operative venous thrombosis. Academic Article
The diagnosis and treatment of thrombosis in the cancer patient. Academic Article
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge. Academic Article
The direct thrombin inhibitor hirudin Academic Article
The discovery and characterization of a novel nucleotide-based thrombin inhibitor Academic Article
The effect of intermittent pneumatic compression on deep-vein thrombosis and ventilation-free days in critically ill patients with heart failure Academic Article
The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin Academic Article
The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group. Academic Article
The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass Academic Article
The effects of oral anticoagulants in patients with peripheral arterial disease: Rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials Academic Article
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement Academic Article
The emerging role of low-molecular-weight heparin in cardiovascular medicine Academic Article
The endocarditis that was not: an unusual case of heparin-induced thrombocytopenia with unusual complications. Academic Article
The hazards of interrupting anticoagulation therapy in atrial fibrillation Academic Article
The identification of at‐risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH Academic Article
The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis Academic Article
The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate Academic Article
The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE Academic Article
The international normalized ratio. A guide to understanding and correcting its problems Academic Article
The management of anticoagulated patients requiring dental extraction: a cross‐sectional survey of oral and maxillofacial surgeons and hematologists Academic Article
The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians Academic Article
The new oral anticoagulants Academic Article
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study Academic Article
The optimal intensity of oral anticoagulant therapy Academic Article
The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation Academic Article
The paradox of heparin‐induced thrombocytopenia Academic Article
The prognostic utility of ICH-score in anticoagulant related intracerebral hemorrhage Academic Article
The proteolytic action of Arvin on human fibrinogen Academic Article
The proteolytic action of arvin on human fibrinogen Academic Article
The reemergence of aspirin for the prevention of venous thromboembolism. Academic Article
The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation. Academic Article
The risk and prevention of venous thromboembolism in the pregnant traveller Academic Article
The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia Academic Article
The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding Academic Article
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial Academic Article
The safety of antithrombotic therapy during pregnancy Academic Article
The safety of co-administered continuous epidural analgesia and low-molecular-weight heparin after major orthopedic surgery: Assessment of a standardized patient management protocol Academic Article
The safety of fondaparinux for the prevention and treatment of venous thromboembolism Academic Article
The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia Academic Article
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group. Academic Article
The significance of new onset atrial fibrillation complicating acute myocardial infarction Academic Article
The status of new anticoagulants Academic Article
The top 4 advances in antithrombotic care in the last year Academic Article
The treatment of venous thromboembolism. Academic Article
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis Academic Article
The use of low molecular weight heparin in pediatric patients: A prospective cohort study Academic Article
The use of low molecular weight heparins in pediatrics: Two cases that highlight potential risks to patient safety Academic Article
The use of the evacuated blood collection tube in the determination of plasma betathromboglobulin Academic Article
The use of well‐characterized sera for the assessment of new diagnostic enzyme‐immunoassays for the diagnosis of heparin‐induced thrombocytopenia Academic Article
The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive value Academic Article
The value of novel oral anticoagulants in rural Australia Academic Article
The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance Academic Article
The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation Academic Article
The worcester venous thromboembolism study Academic Article
The “parallel-cohort RCT”: Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism Academic Article
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 Academic Article
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 Academic Article
Therapeutic Range for the Control of Oral Anticoagulant Therapy Academic Article
Therapeutic strategies for thrombosis: new targets and approaches Academic Article
Therapy of deep vein thrombosis. Academic Article
Therapy of unstable angina with the low molecular weight heparins Academic Article
There seems to be no benefit from using ε-aminocaproic acid in addition to routine postextraction advice in patients receiving anticoagulation therapy Academic Article
Think of HIT When Thrombosis Follows Heparin Academic Article
Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared With Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation Academic Article
Thoracoscopic Left Atrial Appendage Occlusion Academic Article
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis Academic Article
Three challenges described for identifying participants with missing data in trials reports, and potential solutions suggested to systematic reviewers Academic Article
Thrombin activation rate constant: One-stage chromogenic assay for the extrinsic system Academic Article
Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes Academic Article
Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis Academic Article
Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]) Academic Article
Thrombocytopénie induite par l’héparine Academic Article
Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study Conference Paper
Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants Academic Article
Thromboembolic complications in children with cancer Academic Article
Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management Academic Article
Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding Academic Article
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum Academic Article
Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators. Academic Article
Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy Academic Article
Thromboembolism and anticoagulant management in hemodialysis patients: A practical guide to clinical management Academic Article
Thromboembolism and pregnancy. Academic Article
Thromboembolism in Infants and Children With Gastrointestinal Failure Receiving Long-Term Parenteral Nutrition Academic Article
Thromboembolism in children with sarcoma Academic Article
Thromboembolism prevention in ischaemic stroke Academic Article
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism Academic Article
Thrombolysis by chemically modified coagulation factor Xa Academic Article
Thrombolytic Therapy for Submassive Pulmonary Embolism? Academic Article
Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Academic Article
Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis Academic Article
Thrombophilia and New Anticoagulant Drugs Academic Article
Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ? Academic Article
Thromboprophylaxis After Hip or Knee Arthroplasty Academic Article
Thromboprophylaxis after Knee Arthroscopy Academic Article
Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: a network meta-analysis Academic Article
Thromboprophylaxis during chemotherapy: NO Academic Article
Thromboprophylaxis for hospitalized medical patients: A Multicenter Qualitative study Academic Article
Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis Academic Article
Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin Academic Article
Thromboprophylaxis in medical-surgical intensive care unit patients Academic Article
Thromboprophylaxis in surgical patients. Academic Article
Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients Academic Article
Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit Academic Article
Thromboprophylaxis practice patterns in hip fracture surgery patients: experience in Perth, Western Australia Academic Article
Thromboprophylaxis practice patterns in two Western Australian teaching hospitals. Academic Article
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials Academic Article
Thromboprophylaxis with dalteparin in medical patients: which patients benefit? Academic Article
Thrombosis and anticoagulation in the setting of renal or liver disease Academic Article
Thrombosis and anticoagulation. Academic Article
Thrombosis and embolism in pediatric cardiomyopathy Academic Article
Thrombosis in Children Academic Article
Thrombosis in pregnancy Academic Article
Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial Academic Article
Thrombotic Complications and Thromboprophylaxis Across All Three Stages of Single Ventricle Heart Palliation Academic Article
Thrombotic Complications of Neonates and Children with Congenital Nephrotic Syndrome Academic Article
Thrombotic Disorders: Diagnosis and Treatment Academic Article
Thrombotic End Point for Assessing Argatroban Therapy for Heparin-Induced Thrombocytopenia Academic Article
Thrombotic Risk in the Antiphospholipid Syndrome Academic Article
Time in therapeutic range: Warfarin anticoagulation for atrial fibrillation in a community-based practice. Academic Article
Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin Academic Article
Timing the First Postoperative Dose of Anticoagulants Academic Article
To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections Academic Article
To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment Academic Article
Tossing a coin or using common sense Academic Article
Transesophageal echocardiography in patients with cryptogenic ischemic stroke: A systematic review Academic Article
Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. Academic Article
Transient Global Amnesia as the Presenting Feature of Heparin-Induced Thrombocytopenia Academic Article
Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism Academic Article
Translational Success Stories Academic Article
Treatment Algorithm in Cancer-Associated Thrombosis: Canadian Expert Consensus Academic Article
Treatment and Prevention of Heparin-Induced Thrombocytopenia Academic Article
Treatment and prophylaxis of venous thromboembolism during pregnancy Academic Article
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Academic Article
Treatment of Deep-Vein Thrombosis Academic Article
Treatment of First Episode of Venous Thrombosis Academic Article
Treatment of Heparin-Induced Thrombocytopenia Academic Article
Treatment of Proximal Deep Vein Thrombosis With a Novel Synthetic Compound (SR90107A/ORG31540) With Pure Anti–Factor Xa Activity Academic Article
Treatment of Venous Thromboembolism Academic Article
Treatment of Venous Thromboembolism in Cancer Patients Academic Article
Treatment of Venous Thromboembolism with New Oral Anticoagulants According to Patient Risk Academic Article
Treatment of Venous Thrombosis in the Cancer Patient Academic Article
Treatment of acute pulmonary embolism with dabigatran versus warfarin Academic Article
Treatment of bleeding complications in patients on anticoagulant therapy Academic Article
Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management Academic Article
Treatment of deep vein thrombosis: what factors determine appropriate treatment? Academic Article
Treatment of idiopathic pulmonary fibrosis: a network meta-analysis Academic Article
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Academic Article
Treatment of venous thromboembolic disease. Academic Article
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study Academic Article
Treatment of venous thromboembolism with dabigatran Academic Article
Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial Academic Article
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer Academic Article
Treatment with novel oral anticoagulants Academic Article
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial Academic Article
Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018 Academic Article
Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014 Academic Article
Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters Academic Article
Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users Academic Article
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF Academic Article
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study Academic Article
Unanswered questions in venous thromboembolism Academic Article
Uncertainty in the minimum event risk to justify treatment was evaluated Academic Article
Underpowered observational studies create confusion regarding clinical impact of surgical interventions Academic Article
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis Academic Article
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns Academic Article
Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels Academic Article
Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis Academic Article
Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder Academic Article
Unraveling Severe Sepsis Academic Article
Unresolved issues in anticoagulant therapy Conference Paper
Unusual presentation of renal vein thrombosis with pulmonary artery embolism Academic Article
Update on heparin: what do we need to know? Academic Article
Update on the Treatment of Venous Thromboembolism Academic Article
Updates in thrombosis in pediatrics: where are we after 20 years? Academic Article
Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry Academic Article
Upstream anticoagulation for patients with ST‐elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial Academic Article
Urgent Need to Measure Effects of Direct Oral Anticoagulants Academic Article
Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review Academic Article
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial Academic Article
Use and Underuse of Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Old and New Paradigms Academic Article
Use of Alternative Medicines by Patients with OA that Adversely Interact with Commonly Prescribed Medications Academic Article
Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions Academic Article
Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis Academic Article
Use of a single anti-Xa calibration curve is adequate for monitoring enoxaparin and tinzaparin levels in children Academic Article
Use of anticoagulants during pregnancy. Academic Article
Use of antithrombotic agents during pregnancy. Academic Article
Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. Academic Article
Use of decision aids for shared decision making in venous thromboembolism: A systematic review Academic Article
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Academic Article
Use of genetic data to guide therapy in arterial disease Academic Article
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol Academic Article
Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients Academic Article
Use of selective factor Xa inhibitors in special populations. Academic Article
Using low molecular weight heparin in special patient populations Academic Article
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation Academic Article
Utility of Unfractionated Heparin in Transradial Cardiac Catheterization: A Systematic Review and Meta-analysis Academic Article
VTE Prophylaxis in Critically Ill Adults Academic Article
VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3 Academic Article
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Academic Article
Validation of a diagnostic approach to exclude recurrent venous thromboembolism Academic Article
Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation. Academic Article
Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives Academic Article
Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study Academic Article
Valvular heart disease and pregnancy part II: management of prosthetic valves Academic Article
Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries Academic Article
Variation in bleeding risk estimates among online calculators Academic Article
Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries Academic Article
Vascular viewpoint Academic Article
Vascular viewpoint Academic Article
Vasoflux, a New Anticoagulant With a Novel Mechanism of Action Academic Article
Venice Chart International Consensus Document on Atrial Fibrillation Ablation: 2011 Update Academic Article
Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis Academic Article
Venous Thromboembolism Events After Hip Arthroscopy: A Systematic Review Academic Article
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update Academic Article
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014 Academic Article
Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients Academic Article
Venous Thromboembolism and Cancer Academic Article
Venous Thromboembolism and Cancer: Risks and Outcomes Academic Article
Venous Thromboembolism in Hip Fracture Patients: A Subanalysis of the FAITH and HEALTH Trials Academic Article
Venous Thromboembolism in Older Adults: A Community-based Study Academic Article
Venous Thromboembolism in Patients with Chronic Obstructive Pulmonary Disease Academic Article
Venous Thromboembolism in the Outpatient Setting Academic Article
Venous and arterial thrombosis – pathogenesis and the rationale for anticoagulation Academic Article
Venous gangrene of the extremities. Academic Article
Venous limb gangrene and fatal hemorrhage: Adverse consequences of hit “overdiagnosis” in a patient with antiphospholipid syndrome Academic Article
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia Academic Article
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors Academic Article
Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE Academic Article
Venous thromboembolism in heparin-induced thrombocytopenia Academic Article
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada Academic Article
Venous thromboembolism in pregnancy: diagnosis, management and prevention Academic Article
Venous thromboembolism in the elderly Academic Article
Venous thromboembolism management: where do novel anticoagulants fit? Academic Article
Venous thromboembolism prophylaxis in high-risk orthopedic and cancer surgery Academic Article
Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review Academic Article
Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey Academic Article
Venous thromboembolism: A Call for risk assessment in all hospitalised patients Academic Article
Venous thromboembolism: Past, present and future Academic Article
Venous thromboembolism: diagnosis and management of deep venous thrombosis Academic Article
Venous thromboembolism: diagnosis and management of pulmonary embolism Academic Article
Venous thrombosis Academic Article
Venous thrombosis and hyperhomocysteinaemia Academic Article
Venous thrombosis in children Academic Article
Venous thrombosis in children Academic Article
Venous thrombosis in inflammatory bowel disease Academic Article
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism Academic Article
Vitamin K Antagonists and Risk of Subdural Hematoma Academic Article
Vitamin K antagonists in heart disease: Current status and perspectives (Section III) Academic Article
Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis Academic Article
Vitamin K for the Treatment of Asymptomatic Coagulopathy Associated with Oral Anticoagulant Therapy Conference Paper
Vitamin K in anticoagulation therapy Academic Article
Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks? Academic Article
Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10 Academic Article
Voting with your fondaparinux Academic Article
Warfarin After Bioprosthetic Aortic Valve Implantation Academic Article
Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K Academic Article
Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios Academic Article
Warfarin Interactions With Antibiotics in the Ambulatory Care Setting Academic Article
Warfarin Is the Preferred Therapy for Patients With Thrombotic APS Academic Article
Warfarin Maintenance Dosing Patterns in Clinical Practice Academic Article
Warfarin Prophylaxis in the Antiphospholipid Antibody Syndrome Academic Article
Warfarin Therapy for Atrial Fibrillation: The Patient's Preference Is Important Academic Article
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial Academic Article
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm Academic Article
Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility Academic Article
Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis Academic Article
Warfarin in Heart Failure Academic Article
Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences. Academic Article
Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty Academic Article
Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis Academic Article
Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome Academic Article
Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden Academic Article
Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more Academic Article
Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery Academic Article
What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review Academic Article
What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin? Academic Article
What Is the Future of Factor XI Inhibitors? Academic Article
What we have learned about direct oral anticoagulant reversal Academic Article
What’s New for DVT Prophylaxis for the Medically Ill Academic Article
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH Academic Article
When guidelines collide Academic Article
When is HIT Really HIT? Academic Article
When is it safe to stop for safety? Academic Article
When the Rubber Meets the Road: Adherence and Persistence with Non–Vitamin K Antagonist Oral Anticoagulants and Old Oral Anticoagulants in the Real World—A Problem or A Myth ? Academic Article
Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulation—And With Which Anticoagulant? Academic Article
Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation? Academic Article
Who Is (Still) Getting HIT? Academic Article
Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass Academic Article
Why Do Patients With Atrial Fibrillation Not Receive Warfarin? Academic Article
Why Is Factor Xa Not a Better Target Than Factor IIa for Therapeutic Inhibition of Coagulation? Academic Article
Why aren't we falling for anticoagulant therapy? Academic Article
Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada? Academic Article
Withdrawal of warfarin after deep vein thrombosis Academic Article
Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment Academic Article
Women’s values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview study Academic Article
Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review Academic Article
Work-related effort thrombosis in a millwright: A case report Academic Article
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update Academic Article
Wound Disruption Following Caesarean Delivery in Women With Class III Obesity: A Retrospective Observational Study Conference Paper
XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America Academic Article
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation Academic Article
XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden. Conference Paper
Ximelagatran for Secondary Prevention of Venous Thromboembolism Academic Article
Ximelagatran for the secondary prevention of venous thromboembolism Academic Article
Ximelagatran in the Clinic: Practical Management of Patients Academic Article
Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation? Academic Article
Ximelagatran or warfarin in atrial fibrillation? Academic Article
Zinc: An important cofactor in haemostasis and thrombosis Academic Article
[Anticoagulants and other drugs effective against thrombosis]. Academic Article
[Antithrombotic treatment of atrial fibrillation]. Academic Article
[Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study]. Academic Article
[Difficulties in obtaining financial support for studies of hemorrhage during treatment with anticoagulants]. Academic Article
[Length of treatment in deep venous thrombosis--some comments]. Academic Article
[Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer]. Academic Article
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update]. Academic Article
[Prevention of deep vein thrombosis and pulmonary thromboembolism]. Academic Article
[Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?]. Academic Article
[Prevention of venous thrombosis in paraplegic patients. An open study of fraxiparin]. Academic Article
[Prothromplex in stead of Beriplex P/N as acute antidote against warfarin]. Academic Article
[The role of heparinoids in the treatment of vascular diseases]. Academic Article
[There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis]. Academic Article
[Venous thromboembolism, warfarin and cancer--a well-known connection]. Academic Article
γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo Academic Article
“Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome Academic Article

Anticoagulants Concept

Vocabulary Service

Overview

subject area of